Stroke

• 

  Subject Areas on Research

  • "Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke. 
  • "Code stroke": hospitalized versus emergency department patients. 
  • "Real world" thoracic endografting: results with the Gore TAG device 2 years after U.S. FDA approval. 
  • 10 most commonly asked questions about carotid artery occlusion. 
  • 10 questions about statins and stroke. 
  • 2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. 
  • 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. 
  • 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force. 
  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. 
  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. 
  • 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. 
  • 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. 
  • 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. 
  • 30-Day risk-standardized mortality and readmission rates after ischemic stroke in critical access hospitals. 
  • 30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals. 
  • 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. 
  • A Bridge to Nowhere? Benefits and Risks for Periprocedural Anticoagulation in Atrial Fibrillation. 
  • A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. 
  • A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. 
  • A Modified Transcranial Middle Cerebral Artery Occlusion Model to Study Stroke Outcomes in Aged Mice. 
  • A One-Year Follow-Up Study on Community Dwelling Multiple Stroke Survivors with Spatial Neglect. 
  • A Person-Centered Approach to Poststroke Care: The COMprehensive Post-Acute Stroke Services Model. 
  • A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association. 
  • A Simple Score That Predicts Paroxysmal Atrial Fibrillation on Outpatient Cardiac Monitoring after Embolic Stroke of Unknown Source. 
  • A Standardized and Regionalized Network of Care for Cardiogenic Shock. 
  • A Supervised Approach to Robust Photoplethysmography Quality Assessment. 
  • A blood-based biomarker panel to detect acute stroke. 
  • A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale. 
  • A comparison of two stroke cohorts cared for by two different specialties in a practice-based tele-stroke population. 
  • A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre. 
  • A discrete-choice experiment of United Kingdom patients' willingness to risk adverse events for improved function and pain control in osteoarthritis. 
  • A dynamic simulation framework for CT perfusion in stroke assessment built from first principles. 
  • A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. 
  • A geographic information system analysis of the impact of a statewide acute stroke emergency medical services routing protocol on community hospital bypass. 
  • A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation. 
  • A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease. 
  • A link to improve stroke patient care: a successful linkage between a statewide emergency medical services data system and a stroke registry. 
  • A locus mapping to mouse chromosome 7 determines infarct volume in a mouse model of ischemic stroke. 
  • A mathematical model for persistent post-CSD vasoconstriction. 
  • A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. 
  • A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. 
  • A multimethod quality improvement intervention to improve preventive cardiovascular care: a cluster randomized trial. 
  • A new era of anticoagulation treatment: optimizing outcomes for atrial fibrillation. 
  • A new technique allowing prolonged temporary cerebral artery occlusion. 
  • A novel emboli protection cannula during cardiac surgery: in vitro results. 
  • A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development. 
  • A pint of sweat will save a gallon of blood: a call for randomized trials of anticoagulation in end-stage renal disease. 
  • A preliminary investigation into the psychometric properties of the Dublin Extrapersonal Neglect Assessment (DENA): A novel screening tool for extrapersonal neglect. 
  • A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk. 
  • A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. 
  • A randomized controlled trial on Stroke telerehabilitation: The effects on falls self-efficacy and satisfaction with care. 
  • A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial. 
  • A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation. 
  • A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage. 
  • A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE. 
  • A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation. 
  • A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke. 
  • A scoring system derived from electronic health records to identify patients at high risk for noninvasive ventilation failure. 
  • A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes. 
  • A systematic review and meta-analysis of stroke rates in patients undergoing thoracic endovascular aortic repair for descending thoracic aortic aneurysm and type B dissection. 
  • A tale of two centrifugal left ventricular assist devices. 
  • A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. 
  • A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade. 
  • ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF. 
  • ACP Journal Club. In atrial fibrillation, the ATRIA risk score better predicted stroke than CHADS2 and CHA2DS2-VASc scores. 
  • AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. 
  • Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study. 
  • Ablation of atrial fibrillation during coronary artery bypass grafting: Late outcomes in a Medicare population. 
  • Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. 
  • Absence of July Phenomenon in Acute Ischemic Stroke Care Quality and Outcomes. 
  • Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke. 
  • Accuracy of ICD-9-CM Codes by Hospital Characteristics and Stroke Severity: Paul Coverdell National Acute Stroke Program. 
  • Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study. 
  • Accuracy of self-reported stroke among elderly veterans. 
  • Achievement and quality measure attainment in patients hospitalized with atrial fibrillation: Results from The Get With The Guidelines - Atrial Fibrillation (GWTG-AFIB) registry. 
  • Activation of the ATF6 branch of the unfolded protein response in neurons improves stroke outcome. 
  • Acute Ischemic Stroke, Depressed Left Ventricular Ejection Fraction, and Sinus Rhythm: Prevalence and Practice Patterns. 
  • Acute Ischemic Stroke. 
  • Acute ischaemic stroke interventions: large vessel occlusion and beyond. 
  • Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale. 
  • Acute silent cerebral ischemic events in children with sickle cell anemia. 
  • Acute stroke imaging research roadmap. 
  • Acute type a dissection: impact of antegrade cerebral perfusion under moderate hypothermia. 
  • Adding injury to insult: fracture risk after stroke in veterans. 
  • Additional Factors in Considering Patent Foramen Ovale Closure to Prevent Recurrent Ischemic Stroke. 
  • Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients. 
  • Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012. 
  • Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation. 
  • Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation Is Achievable. 
  • Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-hour exclusions and association with outcome: data from Get with the Guidelines-Stroke. 
  • Adherence to postacute rehabilitation guidelines is associated with functional recovery in stroke. 
  • Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. 
  • Adiposity and risk of ischaemic and haemorrhagic stroke in 0·5 million Chinese men and women: a prospective cohort study. 
  • Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial. 
  • Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health. 
  • Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis. 
  • Advanced Practice Provider Versus Physician-Only Outpatient Follow-Up After Acute Myocardial Infarction. 
  • Advanced heart failure treated with continuous-flow left ventricular assist device. 
  • Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies. 
  • Advances in Remote Monitoring for Stroke Recovery. 
  • Advances in Stroke 2017. 
  • Advances in Stroke: Treatments-Preventive. 
  • Advances in Stroke: Treatments-Preventive. 
  • Advances in prevention and health services delivery 2007. 
  • Advances in prevention and health services delivery 2009. 
  • Advances in prevention and health services delivery 2010-2011. 
  • Advances in primary prevention and health services delivery. 
  • Advances in primary stroke prevention. 
  • Advances in stroke: Prevention and health services delivery 2012-2013. 
  • Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. 
  • Aerobic exercise training in stroke survivors. 
  • Age accounts for racial differences in ischemic stroke volume in a population-based study. 
  • Age, Race and Cardiovascular Outcomes in African American Veterans. 
  • Age-Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease. 
  • Age-related declines in activity level: the relationship between chronic illness and religious activities. 
  • Age-related macular degeneration and long-term risk of stroke subtypes. 
  • Age-related macular degeneration and mortality from cardiovascular disease or stroke. 
  • Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study. 
  • Age-related macular degeneration: why should stroke physicians care? 
  • Aggressiveness of care following intracerebral hemorrhage in women and men. 
  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. 
  • All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System. 
  • Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study. 
  • Alternative Payment Models and Associations With Stroke Outcomes, Spending, and Service Utilization: A Systematic Review. 
  • Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial. 
  • Alternatives to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a look back at the state of the field in 2012. 
  • American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. 
  • Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial. 
  • Amphetamine trials and tribulations. 
  • Amphetamines and related drugs in motor recovery after stroke. 
  • An Outcome Model for Intravenous rt-PA in Acute Ischemic Stroke. 
  • An audit of the impact of implementation of a stroke care pathway in an acute teaching hospital. 
  • An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial. 
  • An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial. 
  • An optimal Wilcoxon-Mann-Whitney test of mortality and a continuous outcome. 
  • An update on the unfolded protein response in brain ischemia: Experimental evidence and therapeutic opportunities. 
  • Analysis of Neurologic Complications After Surgical Versus Transcatheter Aortic Valve Replacement. 
  • Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke. 
  • Analysis of pathways mediating preserved vision after striate cortex lesions. 
  • Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization. 
  • Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. 
  • Anesthesia in Experimental Stroke Research. 
  • Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. 
  • Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. 
  • Anterior-to-posterior circulation approach for mechanical thrombectomy of an acutely occluded basilar artery using the penumbra aspiration system. 
  • Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). 
  • Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). 
  • Anticoagulation Resumption After Stroke from Atrial Fibrillation. 
  • Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study. 
  • Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada. 
  • Anticoagulation in Acute Neurological Disease. 
  • Anticoagulation in atrial fibrillation. 
  • Anticoagulation strategies for the management of postoperative atrial fibrillation. 
  • Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial. 
  • Anticoagulation: choosing the optimal anticoagulant. 
  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. 
  • Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. 
  • Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke. 
  • Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials. 
  • Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. 
  • Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. 
  • Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation. 
  • Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation. 
  • Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update. 
  • Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups. 
  • Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005. 
  • Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. 
  • Antithrombotic therapy for ischemic stroke: guidelines translated for the clinician. 
  • Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). 
  • Antithrombotic therapy in atrial fibrillation. 
  • Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician. 
  • Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry. 
  • Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. 
  • Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes. 
  • Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. 
  • Aortic clamping strategy and postoperative stroke. 
  • Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial. 
  • Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial. 
  • Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. 
  • Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial. 
  • Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial. 
  • Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. 
  • Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. 
  • Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. 
  • Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial. 
  • Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial. 
  • Apixaban to prevent stroke in patients with atrial fibrillation: a review. 
  • Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. 
  • Apixaban versus warfarin in patients with atrial fibrillation. 
  • Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. 
  • Apixaban with antiplatelet therapy after acute coronary syndrome. 
  • Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis. 
  • Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. 
  • Appearance of Meningovascular Neurosyphilis Causing an Acute Ischemic Stroke. 
  • Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillation. 
  • Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial. 
  • Apragmatism: The renewal of a label for communication disorders associated with right hemisphere brain damage. 
  • Aprotinin improves functional outcome but not cerebral infarct size in an experimental model of stroke during cardiopulmonary bypass. 
  • Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. 
  • Are Stroke Survivors Discharged to the Recommended Postacute Setting? 
  • Are acute stroke-ready hospitals ready? 
  • Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar. 
  • Arterial ischemic stroke in an adolescent with presumed perinatal ischemic stroke. 
  • Arterial stiffness and cardiovascular events: the Framingham Heart Study. 
  • Ascertaining Nonfatal Endpoints in Clinical Trials: Central Adjudication Versus Patient Insurance Claims. 
  • Aspirin dose and six-month outcome after an acute coronary syndrome. 
  • Aspirin for prevention of subarachnoid hemorrhage: the stage is set for a randomized controlled trial. 
  • Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention. 
  • Aspirin: it's hard to beat. 
  • Assessing chronic stroke survivors with aphasia sheds light on prevalence of spatial neglect. 
  • Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). 
  • Assessment and provision of rehabilitation among patients hospitalized with acute ischemic stroke in China: Findings from the China National Stroke Registry II. 
  • Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial). 
  • Assessment of Home-Time After Acute Ischemic Stroke in Medicare Beneficiaries. 
  • Assessment of aspiration risk in stroke patients with quantification of voluntary cough. 
  • Assessment of healthcare personnel knowledge of stroke care at a large referral hospital in sub-Saharan Africa - A survey based approach. 
  • Assessment of the patient with hyperacute stroke: imaging and therapy. 
  • Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial. 
  • Association Between Depressive Symptoms and Incident Cardiovascular Diseases. 
  • Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China. 
  • Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion. 
  • Association Between Hospital Private Equity Acquisition and Outcomes of Acute Medical Conditions Among Medicare Beneficiaries. 
  • Association Between Hospital-Documented Atrial Fibrillation and Central Retinal Artery Occlusion. 
  • Association Between Inappropriately Dosed Anticoagulation Therapy With Stroke Severity and Outcomes in Patients With Atrial Fibrillation. 
  • Association Between Neighborhood Socioeconomic Status and 30-Day Mortality and Readmission for Patients With Common Neurologic Conditions. 
  • Association Between Obesity and Cardiovascular Outcomes: A Systematic Review and Meta-analysis of Mendelian Randomization Studies. 
  • Association Between Peripheral Versus Central Access for Alternative Access Transcatheter Aortic Valve Replacement and Mortality and Stroke: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke. 
  • Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. 
  • Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke. 
  • Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk. 
  • Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke. 
  • Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial. 
  • Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. 
  • Association between age and outcomes following thrombectomy for anterior circulation emergent large vessel occlusion is determined by degree of recanalisation. 
  • Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis. 
  • Association between estimated glomerular filtration rate and clinical outcomes in patients with acute ischaemic stroke: results from China National Stroke Registry. 
  • Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. 
  • Association between stroke center hospitalization for acute ischemic stroke and mortality. 
  • Association between vision impairment and cognitive decline in older adults with stroke: Health and Retirement Study. 
  • Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population. 
  • Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies. 
  • Association of Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries With Ischemic Stroke. 
  • Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease. 
  • Association of Kidney Function With 30-Day and 1-Year Poststroke Mortality and Hospital Readmission. 
  • Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial. 
  • Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction. 
  • Association of Physical Activity With Risk of Major Cardiovascular Diseases in Chinese Men and Women. 
  • Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation. 
  • Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans. 
  • Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry. 
  • Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. 
  • Association of Smoking Status With Long-Term Mortality and Health Status After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Association of body mass index with mortality and functional outcome after acute ischemic stroke. 
  • Association of formal and informal care with health-related quality of life and depressive symptoms: findings from the Caring for Adults Recovering from the Effects of Stroke study. 
  • Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. 
  • Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. 
  • Association of in-hospital depression and anxiety symptoms following stroke with 3 months- depression, anxiety and functional outcome. 
  • Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. 
  • Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. 
  • Association of the ankle-brachial index with history of myocardial infarction and stroke. 
  • Associations Between Long-Term Air Pollutant Exposure and 30-Day All-Cause Hospital Readmissions in US Patients With Stroke. 
  • Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation. 
  • Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease. 
  • Associations of Medicaid Expansion With Access to Care, Severity, and Outcomes for Acute Ischemic Stroke. 
  • Associations of toothbrushing behaviour with risks of vascular and nonvascular diseases in Chinese adults. 
  • Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. 
  • Atheromatous disease of the aorta and perioperative stroke. 
  • Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. 
  • Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial. 
  • Atrial Fibrillation and Diabetes Mellitus: Can We Modify Stroke Risk Through Glycemic Control? 
  • Atrial Fibrillation in Cancer Patients: Recognizing Gaps in Care. 
  • Atrial fibrillation ablation in practice: assessing CABANA generalizability. 
  • Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. 
  • Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial. 
  • Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy. 
  • Atrial fibrillation in heart failure: what should we do? 
  • Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. 
  • Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community. 
  • Atrial fibrillation: what do we know about screening and what do we not know about treatment? 
  • Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). 
  • Attentional prioritization in dual-task walking: Effects of stroke, environment, and instructed focus. 
  • Author response: Influence of sodium consumption and associated knowledge on poststroke hypertension in Uganda. 
  • Automated multimodal segmentation of acute ischemic stroke lesions on clinical MR images. 
  • Autoregulation after ischaemic stroke. 
  • Average Temperature, Diurnal Temperature Variation, and Stroke Hospitalizations. 
  • Avoiding aortic clamping during coronary artery bypass grafting reduces postoperative stroke. 
  • B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. 
  • BE-FAST (Balance, Eyes, Face, Arm, Speech, Time): Reducing the Proportion of Strokes Missed Using the FAST Mnemonic. 
  • Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes. 
  • Baseline NIH Stroke Scale is an inferior predictor of functional outcome in the era of acute stroke intervention. 
  • Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). 
  • Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. 
  • Be good, communicate, and collaborate: a qualitative analysis of stakeholder perspectives on adding a chiropractor to the multidisciplinary rehabilitation team. 
  • Behavioral equipoise: a way to resolve ethical stalemates in clinical research. 
  • Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients. 
  • Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation). 
  • Benefits of smoking cessation for longevity. 
  • Binding personal and peripersonal space: evidence from tactile extinction. 
  • Biomarker-based risk prediction in the community. 
  • Biomarkers in atrial fibrillation: investigating biologic plausibility, cause, and effect. 
  • Biomarkers in stroke: when will they impact care? 
  • Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. 
  • Blood Pressure Goals and Clinical Outcomes after Successful Endovascular Therapy: A Multicenter Study. 
  • Blood Pressure Levels in Young Adulthood and Midlife Stroke Incidence in a Diverse Cohort. 
  • Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke. 
  • Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial. 
  • Blood pressure management in patients with acute ischemic stroke. 
  • Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative. 
  • Blood pressure, diabetes, and increased dietary salt associated with stroke--results from a community-based study in Pakistan. 
  • Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation. 
  • Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly. 
  • Branch chain amino acids: biomarkers of health and disease. 
  • Bundled Payment and Care of Acute Stroke: What Does it Take to Make it Work? 
  • Burden of informal care in stroke survivors and its determinants: a prospective observational study in an Asian setting. 
  • C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. 
  • CHA2DS2-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban. 
  • COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care Plans. 
  • CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. 
  • CT perfusion-guided versus time-guided mechanical recanalization in acute ischemic stroke patients. 
  • Can acute clinical outcomes predict health-related quality of life after stroke: a one-year prospective study of stroke survivors. 
  • Can caregivers report their care recipients' post-stroke hospitalizations and outpatient visits accurately? Findings of an Asian prospective stroke cohort. 
  • Can continuous quality improvement be assessed using randomized trials? [see comment]. 
  • Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events? 
  • Canadian Stroke Best Practice Consensus Statement: Acute Stroke Management during pregnancy. 
  • Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy. 
  • Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: Update of the Utstein Resuscitation Registry Template for In-Hospital Cardiac Arrest: A Consensus Report From a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia). 
  • Cardiac Biomarkers Predict Large Vessel Occlusion in Patients with Ischemic Stroke. 
  • Cardiac Dysfunction After Neurologic Injury: What Do We Know and Where Are We Going? 
  • Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial. 
  • Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage. 
  • Cardiology patient page. Heart attack and stroke prevention in women. 
  • Cardiovascular Complications of HIV in Endemic Countries. 
  • Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. 
  • Cardiovascular Diseases in the Patients With Psoriatic Arthritis. 
  • Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical Revascularization: The EUCLID Trial. 
  • Cardiovascular Risk Factor Profiles, Emergency Department Visits, and Hospitalizations for Women and Men with a History of Stroke or Transient Ischemic Attack: A Cross-Sectional Study. 
  • Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults. 
  • Cardiovascular adverse events in the drug-development program of bupropion for smoking cessation: A systematic retrospective adjudication effort. 
  • Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. 
  • Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). 
  • Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial. 
  • Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. 
  • Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease. 
  • Carotid Endarterectomy Versus Carotid Stenting to Treat Carotid Stenosis: There Is More to Than Meets the Eye. 
  • Carotid Endarterectomy to Remove Retained Solitaire Stent Retriever inside Carotid Stent after Mechanical Thrombectomy. 
  • Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. 
  • Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial. 
  • Carotid artery stenting versus carotid endarterectomy. 
  • Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes. 
  • Carotid endarterectomy for stroke prevention in older people. 
  • Carotid endarterectomy in the era of endovascular therapy: still the gold standard. 
  • Carotid endarterectomy versus carotid angioplasty with or without stenting for treatment of carotid artery stenosis: an updated meta-analysis of randomized controlled trials. 
  • Case-control study of thromboembolic events associated with IV immunoglobulin. 
  • Catastrophic acute ischemic stroke after Crotalidae polyvalent immune Fab (ovine)-treated rattlesnake envenomation. 
  • Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report. 
  • Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation-Reply. 
  • Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults. 
  • Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study. 
  • Causal relationship between neuronal activity and cerebral hemodynamics in patients with ischemic stroke. 
  • Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. 
  • Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention. 
  • Centers for medicare and medicaid services medicare data and stroke research: goldmine or landmine? 
  • Central aortic pulse pressure, thrombogenicity and cardiovascular risk. 
  • Central nervous system injury associated with cardiac surgery. 
  • Cerebellum as the normal reference for the detection of increased cerebral oxygen extraction. 
  • Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry. 
  • Cerebral autoregulation and acute ischemic stroke. 
  • Cerebral hemodynamics and cognitive impairment: baseline data from the RECON trial. 
  • Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation--a new target for therapeutic intervention? 
  • Cerebral white matter lesions, retinopathy, and stroke. 
  • Cerebrovascular accident (stroke) in captive, group-housed, female chimpanzees. 
  • Challenges after the first decade of transcatheter aortic valve replacement: focus on vascular complications, stroke, and paravalvular leak. 
  • Challenges in assessing hospital-level stroke mortality as a quality measure: comparison of ischemic, intracerebral hemorrhage, and total stroke mortality rates. 
  • Challenges in atrial fibrillation beyond stroke prevention: keeping patients out of the hospital. 
  • Changes in Informed Consent Policy and Treatment Delays in Stroke Thrombolysis. 
  • Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin? 
  • Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial). 
  • Characteristics of strokes associated with centrifugal flow left ventricular assist devices. 
  • Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. 
  • Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial. 
  • Characterizing major bleeding in patients with nonvalvular atrial fibrillation: a pharmacovigilance study of 27 467 patients taking rivaroxaban. 
  • Charlson Index comorbidity adjustment for ischemic stroke outcome studies. 
  • Chelation therapy and cardiovascular outcomes--in reply. 
  • Chemogenetics-mediated acute inhibition of excitatory neuronal activity improves stroke outcome. 
  • China's response to the rising stroke burden. 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. 
  • Chronic Stroke Outcome Measures for Motor Function Intervention Trials: Expert Panel Recommendations. 
  • Chronic Stroke Sensorimotor Impairment Is Related to Smaller Hippocampal Volumes: An ENIGMA Analysis. 
  • Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial. 
  • Chronic kidney disease and stroke. 
  • Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study. 
  • Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial. 
  • Cigarette Smoking and Incident Stroke in Blacks of the Jackson Heart Study. 
  • Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials. 
  • Clinical Characteristics, Management, and In-Hospital Outcomes in Patients With Stroke or Transient Ischemic Attack in China. 
  • Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry. 
  • Clinical Outcome Measures for Lateropulsion Poststroke: An Updated Systematic Review. 
  • Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. 
  • Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. 
  • Clinical Outcomes in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: Results From the EXSCEL Trial. 
  • Clinical Reasoning: Two see or not two see-Is it really double vision? 
  • Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease. 
  • Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial. 
  • Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function. 
  • Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock. 
  • Clinical application of blood biomarkers in cerebrovascular disease. 
  • Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya. 
  • Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial. 
  • Clinical characteristics of myocardial stunning in acute stroke. 
  • Clinical commentary on "Certain uncertainty: life after stroke from the patient's perspective". 
  • Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. 
  • Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. 
  • Clinical inquiry in stroke: using different perspectives to guide future research. 
  • Clinical outcome as a function of the PR-interval-there is virtue in moderation: data from the Duke Databank for cardiovascular disease. 
  • Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patients. 
  • Clinical outcomes among stroke patients receiving tissue plasminogen activator therapy beyond the 3-hour time window. 
  • Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. 
  • Clinical outcomes at 1 year following transcatheter aortic valve replacement. 
  • Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. 
  • Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial. 
  • Clinical pharmacology of insulin confounds stroke trials. 
  • Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race. 
  • Clinical research in primary stroke prevention: needs, opportunities, and challenges. 
  • Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation. 
  • Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database. 
  • Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. 
  • Clinically relevant reperfusion in acute ischemic stroke: MTT performs better than Tmax and TTP. 
  • Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials. 
  • Clopidogrel efficacy and cigarette smoking status. 
  • Clopidogrel plus aspirin in atrial fibrillation. 
  • Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications. 
  • Coarse Grain Consumption and Risk of Cardiometabolic Diseases: A Prospective Cohort Study of Chinese Adults. 
  • Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke. 
  • Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke? 
  • Cognitive-motor dual-task gait training within 3 years after stroke: A randomized controlled trial. 
  • Combining levodopa and virtual reality-based therapy for rehabilitation of the upper limb after acute stroke: pilot study Part II. 
  • Commentary: Extracranial-intracranial bypass for stroke in 2012: response to the critique of the carotid occlusion surgery study "It was déjà vu all over again". 
  • Commentary: This study failed? 
  • Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. 
  • Community impact of anticoagulation services: rationale and design of the Managing Anticoagulation Services Trial (MAST). 
  • Community socioeconomic status and prehospital times in acute stroke and transient ischemic attack: do poorer patients have longer delays from 911 call to the emergency department? 
  • Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. 
  • Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex. 
  • Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices. 
  • Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. 
  • Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry. 
  • Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients. 
  • Comparing the use of diagnostic imaging and receipt of carotid endarterectomy in elderly black and white stroke patients. 
  • Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. 
  • Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. 
  • Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States. 
  • Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists. 
  • Comparison of Associations of Reduced Estimated Glomerular Filtration Rate With Stroke Outcomes Between Hypertension and No Hypertension. 
  • Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke. 
  • Comparison of Outcomes of Ischemic Stroke Initially Imaged With Cranial Computed Tomography Alone vs Computed Tomography Plus Magnetic Resonance Imaging. 
  • Comparison of PET oxygen extraction fraction methods for the prediction of stroke risk. 
  • Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry. 
  • Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. 
  • Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. 
  • Comparison of fondaparinux and enoxaparin in acute coronary syndromes. 
  • Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists. 
  • Comparison of performance achievement award recognition with primary stroke center certification for acute ischemic stroke care. 
  • Comparison of risk scores for the prediction of stroke in African Americans: Findings from the Jackson Heart Study. 
  • Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus. 
  • Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). 
  • Comparison of two depression measures for predicting stroke outcomes. 
  • Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy. 
  • Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. 
  • Compliance with acute stroke care quality measures in hospitals with and without primary stroke center certification: the North Carolina Stroke Care Collaborative. 
  • Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. 
  • Components and Trends in Door to Treatment Times for Endovascular Therapy in Get With The Guidelines-Stroke Hospitals. 
  • Composite outcomes in coronary bypass surgery versus percutaneous intervention. 
  • Comprehensive Stroke Care and Outcomes: Time for a Paradigm Shift. 
  • Computed tomography: revolutionizing the practice of medicine for 40 years. 
  • Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: report of a case imaged serially by MRA over four years. 
  • Concerns for the reliability and validity of the National Stroke Project Stroke Severity Scale. 
  • Concomitant carotid endarterectomy and cardiac surgery does not decrease postoperative stroke rates. 
  • Concordance Between Patient-Reported Health Data and Electronic Health Data in the ADAPTABLE Trial. 
  • Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. 
  • Considerations for Long-Term Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and Cancer. 
  • Constraint-Induced Aphasia Therapy for Treatment of Chronic Post-Stroke Aphasia: A Randomized, Blinded, Controlled Pilot Trial. 
  • Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry. 
  • Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? 
  • Contemporary outcome measures in acute stroke research: choice of primary outcome measure. 
  • Contemporary outcomes after distal vertebral reconstruction. 
  • Contemporary trends and predictors of postacute service use and routine discharge home after stroke. 
  • Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation. 
  • Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. 
  • Contribution of the Veterans Health Administration in understanding racial disparities in access and utilization of health care: a spirit of inquiry. 
  • Control Beliefs and Risk for Death, Stroke and Myocardial Infarction in Middle-aged and Older Adults: An Observational Study. 
  • Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease. 
  • Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Correction of anemia with epoetin alfa in chronic kidney disease. 
  • Correlation between pre-admission blood pressure and outcome in a large telestroke cohort. 
  • Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke. 
  • Corticospinal tract lesion load: An imaging biomarker for stroke motor outcomes. 
  • Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation. 
  • Cost, utilization, and policy of provision of assistive technology devices to veterans poststroke by Medicare and VA. 
  • Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review. 
  • Cost-Effectiveness of Left Atrial Appendage Occlusion: A Case Based on Facts Not in Evidence? 
  • Cost-effectiveness analysis of therapy for symptomatic carotid occlusion: PET screening before selective extracranial-to-intracranial bypass versus medical treatment. 
  • Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT). 
  • Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty. 
  • Cost-effectiveness of ximelagatran for stroke prevention. 
  • Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation. 
  • Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials. 
  • Crossmodal and sensorimotor integration in tactile awareness. 
  • Current Practice Trends for Use of Early Venous Thromboembolism Prophylaxis After Intracerebral Hemorrhage. 
  • Current best practices and guidelines. Assessment and management of complications in infective endocarditis. 
  • Current clinical practice in the screening and diagnosis of spatial neglect post-stroke: Findings from a multidisciplinary international survey. 
  • Current quality of cardiovascular prevention for Million Hearts: an analysis of 147,038 outpatients from The Guideline Advantage. 
  • Current status of percutaneous PFO closure. 
  • D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial. 
  • Dabigatran Compared With Rivaroxaban vs Warfarin. 
  • Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. 
  • Dabigatran versus warfarin in patients with mechanical heart valves. 
  • Dabigatran-related coagulopathy: when can we assume the effect has "worn off"? 
  • Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis. 
  • Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. 
  • Darapladib for preventing ischemic events in stable coronary heart disease. 
  • Data Do Not Support Selection by Target Perfusion Mismatch of Patients for Endovascular Stroke Treatment Within the 16- to 24-Hour Interval. 
  • Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit. 
  • Day-by-Day Variability of Home Blood Pressure and Incident Cardiovascular Disease in Clinical Practice: The J-HOP Study (Japan Morning Surge-Home Blood Pressure). 
  • Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry. 
  • Declining prevalence of dementia in the U.S. elderly population. 
  • Declining stroke mortality in young adults: hope and concern. 
  • Decompressive hemicraniectomy in pediatric patients with malignant middle cerebral artery infarction: case series and review of the literature. 
  • Decreasing the morbidity, mortality, and cost of stroke through awareness and prevention. 
  • Deficiency of Adenosine Deaminase 2 in Adults and Children: Experience From India. 
  • Defining the ischemic penumbra using magnetic resonance oxygen metabolic index. 
  • Delay between stroke onset and emergency department evaluation. 
  • Delayed recognition of Type II decompression sickness in a diver with chronic atrial fibrillation. 
  • Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke. 
  • Delays in fibrinolysis as primary reperfusion therapy for acute ST-segment elevation myocardial infarction. 
  • Demographic and clinical variation in Veterans Health Administration provision of assistive technology devices to veterans poststroke. 
  • Depression Characterization and Race Among Stroke Survivors Receiving Inpatient Rehabilitation. 
  • Depression Status Is Associated with Functional Decline Over 1-Year Following Acute Stroke. 
  • Depression and Functional Status Among African American Stroke Survivors in Inpatient Rehabilitation. 
  • Depression and other determinants of values placed on current health state by stroke patients: evidence from the VA Acute Stroke (VASt) study. 
  • Depression as a contributing factor in cerebrovascular disease. 
  • Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study. 
  • Derivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured rat. 
  • Descending Aortic Distensibility and Cardiovascular Outcomes: A Cardiac Magnetic Resonance Imaging Study. 
  • Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial. 
  • Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy. 
  • Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS). 
  • Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. 
  • Design of the silent cerebral infarct transfusion (SIT) trial. 
  • Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. 
  • Detection of Atrial Fibrillation After Central Retinal Artery Occlusion. 
  • Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). 
  • Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. 
  • Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Development and Assessment of a Computer Algorithm for Stroke Vascular Localization Using Components of the National Institutes of Health Stroke Scale. 
  • Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease. 
  • Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry. 
  • Development, validation, and application of a microsimulation model to predict stroke and mortality in medically managed asymptomatic patients with significant carotid artery stenosis. 
  • Developments in Neurovascular Diseases and Treatments. 
  • Device-Sizing and Associated Complications With Left Atrial Appendage Occlusion: Findings From the NCDR LAAO Registry. 
  • Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke. 
  • Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. 
  • Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up. 
  • Diagnosis and Management of VTE in Pregnancy. 
  • Diagnosis of stroke by emergency medical dispatchers and its impact on the prehospital care of patients. 
  • Diagnostic evaluation for patients with ischemic stroke: are there sex differences? 
  • Diagnostic testing for coagulopathies in patients with ischemic stroke. 
  • Dietary intakes consistent with the DASH dietary pattern reduce blood pressure increase with age and risk for stroke in a Chinese population. 
  • Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization. 
  • Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation. 
  • Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous coronary intervention. 
  • Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction. 
  • Differences in the oral health status in hospitalised stroke patients according to swallowing function: A cross-sectional study. 
  • Different Strokes for Different Folks. 
  • Differential Risk Factors and Outcomes of Ischemic Stroke due to Cervical Artery Dissection in Young Adults. 
  • Differential associations of cortical and subcortical cerebral atrophy with retinal vascular signs in patients with acute stroke. 
  • Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome. 
  • Differentiating intraparenchymal hemorrhage from contrast extravasation on post-procedural noncontrast CT scan in acute ischemic stroke patients undergoing endovascular treatment. 
  • Diffusion-weighted MR imaging in acute stroke: theoretic considerations and clinical applications. 
  • Diffusional Kurtosis Imaging and Motor Outcome in Acute Ischemic Stroke. 
  • Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). 
  • Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). 
  • Discriminative capacity of biomarkers for acute stroke in the emergency department. 
  • Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study. 
  • Disease understanding in patients newly diagnosed with atrial fibrillation. 
  • Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice. 
  • Disparities in Inter-hospital Helicopter Transportation for Hispanics by Geographic Region: A Threat to Fairness in the Era of Thrombectomy. 
  • Disparities in Internet Use Among US Stroke Survivors: Implications for Telerehabilitation During COVID-19 and Beyond. 
  • Distinguishing Arterial Ischemic Stroke From Hypoxic-Ischemic Encephalopathy in the Neonate at Birth. 
  • Distribution of ankle--brachial index and the risk factors of peripheral artery disease in a multi-ethnic Asian population. 
  • Do anticoagulation management services improve care? Implications of the Managing Anticoagulation Services Trial. 
  • Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry. 
  • Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE Trial. 
  • Does a helping hand mean a heavy heart? Helping behavior and well-being among spouse caregivers. 
  • Does diet influence the retinal microvasculature in children? 
  • Does diffusion-weighted imaging represent the ischemic core? An evidence-based systematic review. 
  • Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. 
  • Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. 
  • Dose-adjusted warfarin: writing the prescription is only the beginning. 
  • Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. 
  • Dronedarone in high-risk permanent atrial fibrillation. 
  • Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial. 
  • Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. 
  • Dual-Task Effects on Story Retell for Participants With Moderate, Mild, or No Aphasia: Quantitative and Qualitative Findings. 
  • Dual-function injectable angiogenic biomaterial for the repair of brain tissue following stroke. 
  • Duty cycle dependence of ultrasound enhanced thrombolysis in a human clot model. 
  • Dyadic approach to post-stroke hospitalizations: role of caregiver and patient characteristics. 
  • Dyadic approach to supervised community rehabilitation participation in an Asian setting post-stroke: exploring the role of caregiver and patient characteristics in a prospective cohort study. 
  • Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial. 
  • Dysnomia, ataxia, choreoathetosis, sensory impairment, and gait imbalance after lentiform nucleus stroke. 
  • Dysphagia screening and hospital-acquired pneumonia in patients with acute ischemic stroke: findings from Get with the Guidelines--Stroke. 
  • Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome). 
  • Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source. 
  • Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation. 
  • Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation. 
  • Early biomarkers of stroke. 
  • Early changes of tissue perfusion after tissue plasminogen activator in hyperacute ischemic stroke. 
  • Early ischaemic and haemorrhagic complications after atrial fibrillation-related ischaemic stroke: analysis of the IAC study. 
  • Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. 
  • Early versus delayed invasive intervention in acute coronary syndromes. 
  • Early-onset stroke and vasculopathy associated with mutations in ADA2. 
  • Eating yourself to a stroke? 
  • Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin. 
  • Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis. 
  • Echocardiography for the detection of cardiac sources of embolism in patients with stroke or transient ischemic attack. 
  • Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. 
  • Editorial comment--Advertising strategies to increase the public knowledge of the warning signs of stroke. 
  • Editorial comment--Prenatal influences on stroke mortality in England and Wales. 
  • Editorial comment--what can models teach us about stroke treatment? Sorting out the missing bits. 
  • Edoxaban versus warfarin in patients with atrial fibrillation. 
  • Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES. 
  • Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect. 
  • Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]). 
  • Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. 
  • Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial. 
  • Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation: The SETPOINT2 Randomized Clinical Trial. 
  • Effect of Falls on Frequency of Atrial Fibrillation and Mortality Risk (from the REasons for Geographic And Racial Differences in Stroke Study). 
  • Effect of Known Atrial Fibrillation and Anticoagulation Status on the Prehospital Identification of Large Vessel Occlusion. 
  • Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. 
  • Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants: A Randomized Clinical Trial. 
  • Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial. 
  • Effect of Missed Items on the Reliability of the Kessler Foundation Neglect Assessment Process. 
  • Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis. 
  • Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF). 
  • Effect of a Multifaceted Quality Improvement Intervention on Hospital Personnel Adherence to Performance Measures in Patients With Acute Ischemic Stroke in China: A Randomized Clinical Trial. 
  • Effect of a clinical stroke on the risk of dementia in a prospective cohort. 
  • Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. 
  • Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. 
  • Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis. 
  • Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial. 
  • Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials. 
  • Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. 
  • Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. 
  • Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudy. 
  • Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. 
  • Effect of dual versus mono antiplatelet therapy on recurrent stroke modulated by activated partial thromboplastin time. 
  • Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. 
  • Effect of home testing of international normalized ratio on clinical events. 
  • Effect of insurance status on postacute care among working age stroke survivors. 
  • Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients. 
  • Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry). 
  • Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. 
  • Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation. 
  • Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease. 
  • Effectiveness and safety of carotid artery stenting for significant carotid stenosis in patients with contralateral occlusion (from the German ALKK-CAS Registry experience). 
  • Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): A cluster-randomized controlled trial. 
  • Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. 
  • Effects of Long-Term Vagus Nerve Electrical Stimulation Therapy on Acute Cerebral Infarction and Neurological Function Recovery in Post MCAO Mice. 
  • Effects of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Language Recovery in Poststroke Survivors With Aphasia: An Updated Meta-analysis. 
  • Effects of amphetamines and small related molecules on recovery after stroke in animals and man. 
  • Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA). 
  • Effects of early human immunodeficiency virus infection on cerebral white matter blood flow autoregulation. 
  • Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. 
  • Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis. 
  • Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. 
  • Effects of race and poverty on the process and outcome of inpatient rehabilitation services among stroke patients. 
  • Effects of transcranial direct current stimulation with virtual reality on upper limb function in patients with ischemic stroke: a randomized controlled trial. 
  • Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. 
  • Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial. 
  • Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight. 
  • Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial. 
  • Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation. 
  • Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). 
  • Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. 
  • Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. 
  • Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. 
  • Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. 
  • Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. 
  • Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). 
  • Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial. 
  • Efficacy and safety of aspirin combined with warfarin after acute coronary syndrome : A meta-analysis. 
  • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. 
  • Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials. 
  • Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). 
  • Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial. 
  • Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF. 
  • Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial). 
  • Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF. 
  • Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial. 
  • Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. 
  • Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile. 
  • Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. 
  • Egg Consumption and Risk of Total and Cause-Specific Mortality: An Individual-Based Cohort Study and Pooling Prospective Studies on Behalf of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. 
  • Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack. 
  • Electrocardiographic P terminal force in lead V1, its components, and the association with stroke and atrial fibrillation or flutter. 
  • Electroencephalography During Hemiarch Replacement With Moderate Hypothermic Circulatory Arrest. 
  • Electromyographic (EMG) biofeedback in the comprehensive treatment of central pain and ataxic tremor following thalamic stroke. 
  • Electronic alerts to initiate anticoagulation dialogue in patients with atrial fibrillation. 
  • Embolic strokes of undetermined source: the case for a new clinical construct. 
  • Emergency Consent: Patients' and Surrogates' Perspectives on Consent for Clinical Trials in Acute Stroke and Myocardial Infarction. 
  • Emergency department adherence to American Heart Association guidelines for blood pressure management in acute ischemic stroke. 
  • Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. 
  • Emergency medical services use and its association with acute ischaemic stroke evaluation and treatment in Singapore. 
  • Emergency medical services use by stroke patients: a population-based study. 
  • Emergency medicine in the Veterans Health Administration-results from a nationwide survey. 
  • Emergency response teams in and outside of medicine-structurally crafted to be worlds apart. 
  • Emergent endovascular recanalization for cervical internal carotid artery occlusion in patients presenting with acute stroke. 
  • Emerging Areas of Stroke Rehabilitation Research in Low- and Middle-Income Countries: A Scoping Review. 
  • End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience. 
  • Endothelial cell Pannexin1 modulates severity of ischemic stroke by regulating cerebral inflammation and myogenic tone. 
  • Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. 
  • EndothelinA receptor antagonist BSF-208075 causes immune modulation and neuroprotection after stroke in gerbils. 
  • Endovascular (intraarterial) treatment of acute ischemic stroke: efficacy not supported by clinical trials. 
  • Endovascular Therapies for Acute Ischemic Stroke in Children. 
  • Endovascular Thrombectomy for Anterior Circulation Stroke: Systematic Review and Meta-Analysis. 
  • Endovascular Thrombectomy for Pediatric Acute Ischemic Stroke. 
  • Endovascular intervention for acute ischemic stroke in light of recent trials. 
  • Endovascular management of acute large vessel occlusion stroke in pregnancy is safe and feasible. 
  • Endovascular repair of an acute symptomatic carotid artery dissection through the false dissecting carotid lumen. 
  • Endovascular stroke intervention in the very young. 
  • Endovascular stroke intervention in young patients with large vessel occlusions. 
  • Endovascular transcatheter aortic valve implantation: an evolving standard. 
  • Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial. 
  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. 
  • Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. 
  • Enzyme-Responsive Delivery of Multiple Proteins with Spatiotemporal Control 
  • Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease. 
  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. 
  • Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke. 
  • Ethnic and racial differences of baseline stroke knowledge in a "stroke belt" community. 
  • Evaluating Discrimination of Risk Prediction Models: The C Statistic. 
  • Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke. 
  • Evaluation of Nursing Documentation Completion of Stroke Patients in the Emergency Department: A Pre-Post Analysis Using Flowsheet Templates and Clinical Decision Support. 
  • Evaluation of cerebrovascular reserve capacity in symptomatic and asymptomatic internal carotid stenosis with transcranial Doppler. 
  • Evidence-Based Performance Measures and Outcomes in Patients With Acute Ischemic Stroke. 
  • Evolving role of biomarkers in acute cerebrovascular disease. 
  • Examining the Influence of Social Interactions and Community Resources on Caregivers' Burden in Stroke Settings: A Prospective Cohort Study. 
  • Executive function deficits in acute stroke. 
  • Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. 
  • Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. 
  • Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. 
  • Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI Registry. 
  • Experiences and needs of older adults at different stages of cerebral infarction based on trajectory theory-A qualitative study. 
  • Exploration of a hypothesized independent association of a common 9p21.3 gene variant and ischemic stroke in patients with and without angiographic coronary artery disease. 
  • Exploring patient-provider decision-making for use of anticoagulation for stroke prevention in atrial fibrillation: Results of the INFORM-AF study. 
  • Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes. 
  • Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban). 
  • Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events. 
  • Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. 
  • External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry. 
  • Extracellular vesicles in atrial fibrillation and stroke. 
  • Extracranial carotid artery stenosis. 
  • Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. 
  • Factors associated with 1-year mortality after discharge for acute stroke: what matters? 
  • Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). 
  • Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). 
  • Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation. 
  • Failures to discuss and document preferences: Preventable medical errors in stroke care. 
  • Familial caregiving following stroke: findings from the comprehensive post-acute stroke services (COMPASS) pragmatic cluster-randomized transitional care study. 
  • Family income and cardiovascular disease risk in American adults. 
  • Fatal granulomatous Acanthamoeba encephalitis mimicking a stroke, diagnosed by correlation of results of sequential magnetic resonance imaging, biopsy, in vitro culture, immunofluorescence analysis, and molecular analysis. 
  • Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke. 
  • First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). 
  • First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in Argentina. 
  • Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. 
  • Fluoxetine Maintains a State of Heightened Responsiveness to Motor Training Early After Stroke in a Mouse Model. 
  • Folic acid supplementation and chronic kidney disease progression. 
  • Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. 
  • Foot drop stimulation versus ankle foot orthosis after stroke: 30-week outcomes. 
  • Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. 
  • Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. 
  • Fractal dimension of the retinal vasculature and risk of stroke: a nested case-control study. 
  • Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II). 
  • Frontiers of Upstream Stroke Prevention and Reduced Stroke Inequity Through Predicting, Preventing, and Managing Hypertension and Atrial Fibrillation: A Call to Action From the Value in Healthcare Initiative's Predict & Prevent Learning Collaborative. 
  • Functional assessment of spatial neglect: a review of the Catherine Bergego scale and an introduction of the Kessler foundation neglect assessment process. 
  • Fusion of multiscale wavelet-based fractal analysis on retina image for stroke prediction. 
  • GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation. 
  • Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Gastric acid burns because of a disconnected nasogastric tube. 
  • Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. 
  • Generalizations about general anesthesia: the unsubstantiated condemnation of general anesthesia for patients undergoing intra-arterial therapy for anterior circulation stroke. 
  • Genetic polymorphisms and the risk of stroke after cardiac surgery. 
  • Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. 
  • Genome-Wide Association Study Meta-Analysis of Stroke in 22 000 Individuals of African Descent Identifies Novel Associations With Stroke. 
  • Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease. 
  • Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke. 
  • Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. 
  • Geographic variation in one-year recurrent ischemic stroke rates for elderly Medicare beneficiaries in the USA. 
  • Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. 
  • Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. 
  • Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. 
  • Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. 
  • Glycated hemoglobin measurement and prediction of cardiovascular disease. 
  • Glycemic index, retinal vascular caliber, and stroke mortality. 
  • Glycemic status and the association of change in blood pressure with incident cardiovascular disease. 
  • Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. 
  • Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. 
  • Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012. 
  • Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. 
  • Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. 
  • Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. 
  • Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. 
  • Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. 
  • Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. 
  • Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. 
  • Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. 
  • HVAD: The ENDURANCE Supplemental Trial. 
  • Haemiballism/haemichorea: an atypical presentation of ischaemic stroke. 
  • Harmonized outcome measures for use in atrial fibrillation patient registries and clinical practice: Endorsed by the Heart Rhythm Society Board of Trustees. 
  • Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events. 
  • Have randomized controlled trials of neuroprotective drugs been underpowered? An illustration of three statistical principles. 
  • Head CT deep learning model is highly accurate for early infarct estimation. 
  • Health Services Research. 
  • Health policy and outcome research in stroke. 
  • Health policy and outcomes research 2004. 
  • Health policy in stroke: translating what we know into what we do. 
  • Health-related quality of life loss associated with first-time stroke. 
  • Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. 
  • Healthcare utilization and cost trajectories post-stroke: role of caregiver and stroke factors. 
  • Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. 
  • Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. 
  • Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. 
  • Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. 
  • Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. 
  • Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report. 
  • Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis of stakeholder practices, needs, and barriers. 
  • Heart disease and stroke statistics--2011 update: a report from the American Heart Association. 
  • Heart disease and stroke statistics--2012 update: a report from the American Heart Association. 
  • Heart disease and stroke statistics--2013 update: a report from the American Heart Association. 
  • Heart disease and stroke statistics--2014 update: a report from the American Heart Association. 
  • Heart disease and stroke statistics--2015 update: a report from the American Heart Association. 
  • Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial. 
  • Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. 
  • Hemodynamic benefits of regional anesthesia for carotid endarterectomy. 
  • Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. 
  • Hemostasis and alterations of the central nervous system. 
  • Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. 
  • High-dose atorvastatin after stroke or transient ischemic attack. 
  • High-resolution vessel wall imaging after mechanical thrombectomy. 
  • High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. 
  • High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. 
  • Higher Body Mass Index Increases Risk of HeartMate II Pump Thrombosis But Does Not Adversely Affect Long-Term Survival. 
  • Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin. 
  • Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. 
  • History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke. 
  • History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. 
  • Home-based tele-rehabilitation presents comparable positive impact on self-reported functional outcomes as usual care: The Singapore Tele-technology Aided Rehabilitation in Stroke (STARS) randomised controlled trial. 
  • Home-time Is a Patient-Centered Outcome Variable for Stroke: An Executive Summary. 
  • Homocysteine testing in patients with acute ischemic stroke. 
  • Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. 
  • Hormone replacement therapy and ischemic stroke severity in women: a case-control study. 
  • Hormone therapy: physiological complexity belies therapeutic simplicity. 
  • Hospital Factors Associated With Interhospital Transfer Destination for Stroke in the Northeast United States. 
  • Hospital Quality Metrics: "America's Best Hospitals" and Outcomes After Ischemic Stroke. 
  • Hospital Readmissions and Mortality Among Fee-for-Service Medicare Patients With Minor Stroke or Transient Ischemic Attack: Findings From the COMPASS Cluster-Randomized Pragmatic Trial. 
  • Hospital Variation in Functional Recovery After Stroke. 
  • Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research). 
  • Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. 
  • Hospital distance, socioeconomic status, and timely treatment of ischemic stroke. 
  • Hospital-level variation in mortality and rehospitalization for medicare beneficiaries with acute ischemic stroke. 
  • Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF. 
  • Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes. 
  • Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. 
  • How can modeling best contribute to the assessment of secondary stroke prevention strategies? 
  • How central is central poststroke pain? The role of afferent input in poststroke neuropathic pain: a prospective, open-label pilot study. 
  • How much can be gained by more systematic prevention of stroke? 
  • How strong is the relationship between functional status and quality of life among persons with stroke? 
  • How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Hydrogels for brain repair after stroke: an emerging treatment option 
  • Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. 
  • Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial. 
  • Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial. 
  • Hyperperfusion on perfusion computed tomography following revascularization for acute stroke. 
  • Hypertensive retinopathy and risk of stroke. 
  • IV tPA for acute ischemic stroke: Times are changing. 
  • Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. 
  • Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death. 
  • Imaging preventable infarction in patients with acute ischemic stroke. 
  • Imaging retina to study dementia and stroke. 
  • Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis. 
  • Impact of Cerebral Small Vessel Disease on Functional Recovery After Intracerebral Hemorrhage. 
  • Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome. 
  • Impact of Insurance Status on Outcomes and Use of Rehabilitation Services in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke. 
  • Impact of Patent Foramen Ovale on Total Knee Arthroplasty Cerebrovascular Accident Perioperative Management. 
  • Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation. 
  • Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. 
  • Impact of Stroke Call on the Stroke Neurology Workforce in the United States: Possible Challenges and Opportunities. 
  • Impact of an Expanded Hospital Recognition Program for Stroke Quality of Care. 
  • Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. 
  • Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction). 
  • Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registry. 
  • Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial. 
  • Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. 
  • Impact of comorbidities on ischemic stroke outcomes in women. 
  • Impact of comorbidities on stroke rehabilitation outcomes: does the method matter? 
  • Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. 
  • Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial. 
  • Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. 
  • Impact of metformin use on the cardiovascular effects of dipeptidyl peptidase-4 inhibitors: An analysis of Medicare claims data from 2007 to 2015. 
  • Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF. 
  • Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy. 
  • Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. 
  • Impact of socioeconomic status on stroke incidence: a population-based study. 
  • Impact of spatial neglect on stroke rehabilitation: evidence from the setting of an inpatient rehabilitation facility. 
  • Impacts of Prism Adaptation Treatment on Spatial Neglect and Rehabilitation Outcome: Dosage Matters. 
  • Impaired capacity to restore proteostasis in the aged brain after ischemia: Implications for translational brain ischemia research. 
  • Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis. 
  • Implementation of Best Practices-Developing and Optimizing Regional Systems of Stroke Care: Design and Methodology. 
  • Implementation of a billable transitional care model for stroke patients: the COMPASS study. 
  • Importance and Challenges of Moving Stroke Prevention into the Community. 
  • Important factors in predicting mortality outcome from stroke: findings from the Anglia Stroke Clinical Network Evaluation Study. 
  • Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. 
  • Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke. 
  • Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. 
  • Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. 
  • Improving early clinical trial phase identification of promising therapeutics. 
  • Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke. 
  • Improving stroke education performance measures scores: the impact of a stroke nurse coordinator. 
  • Improving the clinical diagnosis of stroke. 
  • Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial. 
  • Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. 
  • In Reply: May Cooler Heads Prevail During a Pandemic: Stroke in COVID-19 Patients or COVID-19 in Stroke Patients? 
  • In older persons at risk for dementia, a multidomain approach reduced stroke and transient ischemic attack. 
  • In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events. 
  • In-House Anesthesia and Interventional Radiology Technologist Support Optimize Mechanical Thrombectomy Workflow after Hours. 
  • In-hospital outcomes of thrombolysis for acute ischemic stroke in patients with primary brain tumors. 
  • Inability to Consent Does Not Diminish the Desirability of Stroke Thrombolysis 
  • Incidence and Diagnostic Challenges of Bowel Ischemia after Continuous-flow Left Ventricular Assist Device Therapy. 
  • Incidence and Predictors of Adverse Events Among Initially Stable ST-Elevation Myocardial Infarction Patients Following Primary Percutaneous Coronary Intervention. 
  • Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome. 
  • Incidence and occurrence of total (first-ever and recurrent) stroke. 
  • Incidence and predictors of stroke associated with percutaneous coronary intervention. 
  • Incidence and risk factors for stroke in pregnancy and the puerperium. 
  • Incidence of Poststroke Epilepsy: An Executive Summary. 
  • Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques. 
  • Incidence of myocardial infarction, stroke, and death in patients with age-related macular degeneration treated with intravitreal anti-vascular endothelial growth factor therapy. 
  • Incidence of postoperative stroke using the Heartstring device in 1,380 coronary artery bypass graft patients with mild to severe atherosclerosis of the ascending aorta. 
  • Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry. 
  • Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry. 
  • Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study. 
  • Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. 
  • Incorporating patient preferences into clinical trial design: results of the opinions of patients on treatment implications of new studies (OPTIONS) project. 
  • Incorporation of Retinal Arteriolosclerosis into Risk Stratification of Blood Pressure Category According to the 2017 ACC/AHA Blood Pressure Guideline. 
  • Increase in Endovascular Therapy in Get With The Guidelines-Stroke After the Publication of Pivotal Trials. 
  • Increased Left Atrial Appendage Density on Computerized Tomography is Associated with Cardioembolic Stroke. 
  • Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population. 
  • Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke. 
  • Increasing Stroke Knowledge and Decreasing Stroke Risk in a Latino Immigrant Population. 
  • Increasing rates of dementia at time of declining mortality from stroke. 
  • Independent predictors of stroke in patients with atrial fibrillation: a systematic review. 
  • Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry. 
  • Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators. 
  • Individual and Joint Effects of Influenza-Like Illness and Vaccinations on Stroke in the Young: A Case-Control Study: Can You Catch a Stroke? 
  • Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores. 
  • Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project. 
  • Infarct Pattern, Perfusion Mismatch Thresholds, and Recurrent Cerebrovascular Events in Symptomatic Intracranial Stenosis. 
  • Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial. 
  • Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke. 
  • Infectious complications in extended criteria heart transplantation. 
  • Inferolateral thalamic ischemia secondary to PCA P2 perforator occlusion mimics MCA stroke syndrome. 
  • Influence of Dietary Salt Knowledge, Perceptions, and Beliefs on Consumption Choices after Stroke in Uganda. 
  • Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA. 
  • Influence of mild cognitive impairment on patient and care partner decision-making for acute ischemic stroke. 
  • Influence of sodium consumption and associated knowledge on poststroke hypertension in Uganda. 
  • Influence of stent design and use of protection devices on outcome of carotid artery stenting: a pooled analysis of individual patient data. 
  • Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke Program. 
  • Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. 
  • Informal caregivers' burden and stress in caring for stroke survivors with spatial neglect: an exploratory mixed-method study. 
  • Inherited frailty. ApoE alleles determine survival after a diagnosis of heart disease or stroke at ages 85+. 
  • Inherited thrombophilia in childhood arterial stroke: data from Lebanon. 
  • Initial experience with a transcatheter septal closure system for secondary stroke prevention in patients with interatrial septal defects. 
  • Injectable biomaterial shuttles for cell therapy in stroke. 
  • Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke. 
  • Injection of Microporous Annealing Particle (MAP) Hydrogels in the Stroke Cavity Reduces Gliosis and Inflammation and Promotes NPC Migration to the Lesion 
  • Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association? 
  • Integrating tDCS into routine inpatient rehabilitation practice to boost post-stroke recovery. 
  • Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial. 
  • Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes. 
  • Inter- and intrasite variability of mortality and stroke for sites performing both surgical and transcatheter aortic valve replacement for aortic valve stenosis in intermediate-risk patients. 
  • Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial. 
  • Interaction of Blood Pressure and Glycemic Status in Developing Cardiovascular Disease: Analysis of a Nationwide Real-World Database. 
  • Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. 
  • Intermittent Theta Burst Stimulation (iTBS) for Treatment of Chronic Post-Stroke Aphasia: Results of a Pilot Randomized, Double-Blind, Sham-Controlled Trial. 
  • International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke: Analysis of the China National Stroke Registry and the American Heart Association Get With The Guidelines--Stroke Program. 
  • International Comparison of Poststroke Resource Use: A Longitudinal Analysis in Europe. 
  • International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial. 
  • International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin. 
  • International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. 
  • International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation. 
  • Interprofessional Simulation: Creative Ways to Integrate Education and Goal Setting in the Practice Environment. 
  • Interventional and new approaches to stroke prevention: introduction. 
  • Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review. 
  • Intra-arterial therapies for acute ischemic stroke: unsafe and without proven value. 
  • Intra-arterial thrombolytic therapy in peri-coronary angiography ischemic stroke. 
  • Intracerebral haemorrhage, atrial fibrillation, and anticoagulation - Authors' reply. 
  • Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. 
  • Intraoperative physiologic variables and outcome in cardiac surgery: Part II. Neurologic outcome. 
  • Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. 
  • Intravenous Alteplase for Mild Nondisabling Acute Ischemic Stroke: A Bridge Too Far? 
  • Intravenous Tissue Plasminogen Activator in Stroke Mimics. 
  • Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus. 
  • Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. 
  • Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke. 
  • Intravenous thrombolysis of basilar artery thrombosis. 
  • Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death. 
  • Introduction for Focused Updates in Cerebrovascular Disease. 
  • Inverse National Trends in Decompressive Craniectomy versus Endovascular Thrombectomy for Stroke. 
  • Investigating the mechanisms of perioperative ischemic stroke in the Carotid Occlusion Surgery Study. 
  • Investigation of S-Nitrosoglutathione in stroke: A systematic review and meta-analysis of literature in pre-clinical and clinical research. 
  • Invited Commentary. 
  • Iron nanoparticle contrast enhanced microwave imaging for emergent stroke: A pilot study. 
  • Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart. 
  • Is Risk-Standardized In-Hospital Stroke Mortality an Adequate Proxy for Risk-Standardized 30-Day Stroke Mortality Data? Findings From Get With The Guidelines-Stroke. 
  • Is age a key factor contributing to the disparity between success of neuroprotective strategies in young animals and limited success in elderly stroke patients? Focus on protein homeostasis. 
  • Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation. 
  • Is carpal tunnel syndrome present in acute stroke patients? An investigative study using clinical and imaging screening tools. 
  • Is diabetic retinopathy an independent risk factor for ischemic stroke? 
  • Is routine retinal examination useful in patients with acute ischemic stroke? 
  • Is stroke history reliably reported by elderly with cognitive impairment? A community-based study. 
  • Is there a causal relationship between the amount of alcohol consumption and stroke risk? 
  • Is there a period of liability with initiation of warfarin in patients with atrial fibrillation? 
  • Is this patient having a stroke? 
  • Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. 
  • Ischaemic stroke in heart failure: back to basics? 
  • Ischemic Stroke Transfer Patterns in the Northeast United States. 
  • Ischemic Stroke and Internal Carotid Artery Web. 
  • Ischemic Stroke with Troponin Elevation: Patient Characteristics, Resource Utilization, and In-Hospital Outcomes. 
  • Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation. 
  • Ischemic stroke because of intracranial fibromuscular dysplasia. 
  • Ischemic stroke survivors' opinion regarding research utilizing exception from informed consent. 
  • Ischemic stroke: "acidotoxicity" is a perpetrator. 
  • J. Maxwell Chamberlain Memorial Paper for adult cardiac surgery. Less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • JUPITER and the world of stroke medicine. 
  • JURaSSiC: accuracy of clinician vs risk score prediction of ischemic stroke outcomes. 
  • Joining a Multicenter Clinical Trial. 
  • Joint effect of stroke and APOE 4 on dementia risk: the Canadian Study of Health and Aging. 
  • Kessler Foundation Neglect Assessment Process uniquely measures spatial neglect during activities of daily living. 
  • LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA. 
  • Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. 
  • Lack of impact of electronic health records on quality of care and outcomes for ischemic stroke. 
  • Lack of impact of paramedic training and use of the cincinnati prehospital stroke scale on stroke patient identification and on-scene time. 
  • Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. 
  • Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort. 
  • Left Atrial Appendage Morphology Improves Prediction of Stagnant Flow and Stroke Risk in Atrial Fibrillation. 
  • Left Atrial Appendage Morphology and Embolic Stroke of Undetermined Source: A Cross-Sectional Multicenter Pilot Study. 
  • Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis. 
  • Left Atrial Appendage Thrombus and Embolic Stroke. 
  • Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source. 
  • Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. 
  • Left atrial appendage characteristics and the risk of stroke: Sorting out the contenders from the pretenders. 
  • Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation. 
  • Left atrial appendage occlusion: rationale, evidence, devices, and patient selection. 
  • Left atrial enlargement: a cause of stroke? 
  • Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. 
  • Letter by El Husseini et al regarding article, "What causes disability after transient ischemic attack and minor stroke?". 
  • Letter by Moris and Avgerinos Regarding Article, "Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone". 
  • Letter by Moris et al Regarding Article, "One-Year Outcomes After Minor Stroke or High-Risk Transient Ischemic Attack: Korean Multicenter Stroke Registry Analysis". 
  • Letter by Moris et al Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)". 
  • Letter by Van de Werf et al regarding article, "using dabigatran in patients with stroke: a practical guide for clinicians". 
  • Level of consciousness at discharge and associations with outcome after ischemic stroke. 
  • Lifestyle modification and cognitive function among individuals with resistant hypertension: cognitive outcomes from the TRIUMPH trial. 
  • Linked Sensitivity Analysis, Calibration, and Uncertainty Analysis Using a System Dynamics Model for Stroke Comparative Effectiveness Research. 
  • Linking evidence-based medicine therapeutic summary measures to clinical decision analysis. 
  • Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. 
  • Lipids in high-risk patients presenting with ischemic stroke or transient ischemic attack: are we missing the target? 
  • Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations. 
  • Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. 
  • Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease. 
  • Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications. 
  • Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study). 
  • Long-Term Neurocognitive Outcome in Patients With Continuous Flow Left Ventricular Assist Device. 
  • Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction. 
  • Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial. 
  • Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry. 
  • Long-term exposure to ozone and cardiovascular mortality in China: a nationwide cohort study. 
  • Long-term follow-up of continuous flow left ventricular assist devices: complications and predisposing risk factors. 
  • Long-term oral anticoagulant after catheter ablation for atrial fibrillation. 
  • Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. 
  • Long-term outcomes after carotid endarterectomy: can the past be used to predict the future? 
  • Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction. 
  • Long-term outcomes of aortic root operations in the United States among Medicare beneficiaries. 
  • Long-term outcomes of the symmetry vein graft anastomosis device: a matched case-control analysis. 
  • Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. 
  • Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. 
  • Longitudinal fMRI study of language recovery after a left hemispheric ischemic stroke. 
  • Low Blood Pressure Threshold for Adverse Outcomes During Left Ventricular Assist Device Support. 
  • Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. 
  • Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. 
  • Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS. 
  • Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials. 
  • Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial. 
  • Lower incidence of vascular events following small artery ischemic stroke. 
  • Lower stroke risk with lower blood pressure in hemodynamic cerebral ischemia. 
  • Lower stroke-related mortality in counties with stroke centers: North Carolina Stroke Facilities Survey. 
  • Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 
  • MR DWI does not substitute for stroke severity scores in predicting stroke outcome. 
  • MR imaging of oxygen extraction and neurovascular coupling. 
  • Machine learning does not improve upon traditional regression in predicting outcomes in atrial fibrillation: an analysis of the ORBIT-AF and GARFIELD-AF registries. 
  • Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. 
  • Major lipids, apolipoproteins, and risk of vascular disease. 
  • Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry. 
  • Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. 
  • Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry. 
  • Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. 
  • Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]). 
  • Management of hearing in pediatric NF2. 
  • Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. 
  • Management of moyamoya syndrome in patients with Noonan syndrome. 
  • Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database. 
  • Marital History and Survival After Stroke. 
  • Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. 
  • Mechanical Thrombectomy in Distal Vessels: Revascularization Rates, Complications, and Functional Outcome. 
  • Mechanical Thrombectomy in Ischemic Stroke Patients with Severe Pre-Stroke Disability. 
  • Mechanical thrombectomy for perioperative ischemic stroke following elective inpatient surgery in the United States. 
  • Medial premotor cortex shows a reduction in inhibitory markers and mediates recovery in a mouse model of focal stroke. 
  • Medical therapy for acute ischemic stroke. 
  • Medical utilization and cost outcomes for poststroke veterans who receive assistive technology devices from the Veterans Health Administration. 
  • Medicare HMO penetration and mortality outcomes of ischemic stroke. 
  • Medicare Shared Savings ACOs and Hospice Care for Ischemic Stroke Patients. 
  • Medicare claims indicators of healthcare utilization differences after hospitalization for ischemic stroke: Race, gender, and caregiving effects. 
  • Medication errors in acute cardiac care: An American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke. 
  • Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association. 
  • Medication non-adherence after myocardial infarction: an exploration of modifying factors. 
  • Medicine. Stroke--tPA and the clinic. 
  • Meeting Medicare requirements for transitional care: Do stroke care and policy align? 
  • Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research. 
  • Meta-Analysis of Genome-Wide Association Studies Identifies Genetic Risk Factors for Stroke in African Americans. 
  • Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease. 
  • Metabolic syndrome and risk of stroke: Protocol for an update systematic review and meta-analysis. 
  • Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis. 
  • Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. 
  • Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conduct. 
  • Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy. 
  • Microvascular structure and network in the retina of patients with ischemic stroke. 
  • Middle Cerebral Artery Residual Contrast Stagnation on Noncontrast CT Scan Following Endovascular Treatment in Acute Ischemic Stroke Patients. 
  • Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. 
  • Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. 
  • Mirror movements complicate interpretation of cerebral activation changes during recovery from subcortical infarction. 
  • Mobile health as a viable strategy to enhance stroke risk factor control: A systematic review and meta-analysis. 
  • Model of recovery of locomotor ability after sensorimotor cortex injury in rats. 
  • Modeling the Association of Volume vs Composite Outcome Thresholds With Outcomes and Access to Transcatheter Aortic Valve Implantation in the US. 
  • Moderate Versus Deep Hypothermia With Unilateral Selective Antegrade Cerebral Perfusion for Acute Type A Dissection. 
  • Modern medical management of acute ischemic stroke. 
  • Monitoring and improving acute stroke care: The North Carolina Stroke Care Collaborative. 
  • Monte Carlo Simulation Modeling of a Regional Stroke Team's Use of Telemedicine. 
  • Morning and Evening Home Blood Pressure and Risks of Incident Stroke and Coronary Artery Disease in the Japanese General Practice Population: The Japan Morning Surge-Home Blood Pressure Study. 
  • Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. 
  • Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. 
  • Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy. 
  • Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age. 
  • Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study. 
  • Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults. 
  • Motor cortex stimulation and neuropathic facial pain. 
  • Moyamoya syndrome in a young person with Down syndrome: diagnostic and therapeutic considerations. 
  • Multi-objective learning and explanation for stroke risk assessment in Shanxi province. 
  • Multi-stage segmentation of white matter hyperintensity, cortical and lacunar infarcts. 
  • Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. 
  • Multidisciplinary Stroke Pathway for Children Supported With Ventricular Assist Devices. 
  • Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI. 
  • Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation. 
  • N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy. 
  • N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). 
  • NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. 
  • National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond. 
  • National Institutes of Health StrokeNet Training Core. 
  • National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. 
  • National surveillance of stroke quality of care and outcomes by applying post-stratification survey weights on the Get With The Guidelines-Stroke patient registry. 
  • Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. 
  • Natural genetic variation of integrin alpha L (Itgal) modulates ischemic brain injury in stroke. 
  • Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS. 
  • Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study. 
  • Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF. 
  • Neurologic complications of congenital heart disease in adults. 
  • Neurologic outcomes after coronary artery bypass grafting with and without cardiopulmonary bypass. 
  • Neurologic risk assessment, monitoring and outcome in cardiac surgery. 
  • Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration. 
  • Neuroprotection in cardiac surgery. 
  • Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. 
  • Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage. 
  • Neuroprotective therapy for acute ischaemic stroke: down, but not out. 
  • Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. 
  • New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation. 
  • New classes of anticoagulation and antiplatelet agents: preprocedure management and safety guidelines for imaging-guided intervention. 
  • New guidelines to reduce risk of atherosclerotic cardiovascular disease: implications for stroke prevention in 2014. 
  • New horizons in stroke rehabilitation research. 
  • New onset focal weakness in children with Down syndrome. 
  • New transient ischemic attack and stroke: outpatient management by primary care physicians. 
  • New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs. 
  • Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism. 
  • Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. 
  • News coverage and online advertising effects on patient-led search for aspirin, heart health, and stroke information and educational tool use. 
  • Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events. 
  • Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation. 
  • Non-atherosclerotic vascular disease in the young. 
  • Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation. 
  • Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). 
  • Nondisease-specific problems and all-cause mortality in the REasons for Geographic and Racial Differences in Stroke study. 
  • Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis. 
  • Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies. 
  • Nonstenotic carotid plaques: Stroke causation or guilt by association? 
  • Nonsteroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery. 
  • Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF. 
  • North American Thrombosis Forum, AF Action Initiative Consensus Document. 
  • North Carolina stroke prevention and treatment facilities survey. Statewide availability of programs and services. 
  • Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack. 
  • Novel diagnostic test for acute stroke. 
  • Novel oral anticoagulants and reversal agents: Considerations for clinical development. 
  • Novel oral anticoagulants in gastroenterology practice. 
  • Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis. 
  • Novel platelet antiaggregants and the changing landscape of stroke prevention. 
  • Novel risk factors for stroke: homocysteine, inflammation, and infection. 
  • O-linked β-N-acetylglucosamine modification of proteins is activated in post-ischemic brains of young but not aged mice: Implications for impaired functional recovery from ischemic stress. 
  • Ocular Fundus Photography as a Tool to Study Stroke and Dementia. 
  • Odyssey of Patent Foramen Ovale: Closure in Cryptogenic Stroke: The Canary in the Coal Mine of Clinical Trials? 
  • Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry. 
  • Off-hour admission and in-hospital stroke case fatality in the get with the guidelines-stroke program. 
  • Off-label closure during CLOSURE study. 
  • Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting. 
  • On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF. 
  • One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis. 
  • One-year cardiovascular event rates in outpatients with atherothrombosis. 
  • Operating in the Dark: When Is Surgery Necessary for Left Ventricular Assist Device Hemolysis? 
  • Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. 
  • Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation. 
  • Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease. 
  • Oral Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation: The Need to Evaluate Net Clinical Effect. 
  • Oral anticoagulant therapy for the prevention of stroke. 
  • Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. 
  • Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group. 
  • Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs? 
  • Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation. 
  • Oral anticoagulation: a step toward solving the puzzle of dementia related to atrial fibrillation? 
  • Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. 
  • Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation. 
  • Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. 
  • Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial. 
  • Out-of-hospital stroke screen accuracy in a state with an emergency medical services protocol for routing patients to acute stroke centers. 
  • Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. 
  • Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry. 
  • Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). 
  • Outcomes After Endovascular Thrombectomy With or Without Alteplase in Routine Clinical Practice. 
  • Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study. 
  • Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial. 
  • Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers. 
  • Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study. 
  • Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. 
  • Outcomes following transcatheter aortic valve replacement in the United States. 
  • Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease. 
  • Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke. 
  • Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry. 
  • Outcomes of Endovascular Therapy in Patients With Prestroke Mobility Impairment. 
  • Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD2 score. 
  • Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. 
  • Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial. 
  • Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial. 
  • Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. 
  • Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. 
  • Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). 
  • Outcomes of off-pump versus on-pump coronary artery bypass grafting: Impact of preoperative risk. 
  • Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. 
  • Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). 
  • Oxygen metabolism in acute ischemic stroke. 
  • P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack. 
  • P2Y12 receptor inhibitors for secondary prevention of ischemic stroke. 
  • PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites. 
  • PERK (Protein Kinase RNA-Like ER Kinase) Branch of the Unfolded Protein Response Confers Neuroprotection in Ischemic Stroke by Suppressing Protein Synthesis. 
  • PET screening of carotid occlusion. 
  • Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial. 
  • Palliative treatment of dysphonia and dysarthria. 
  • Pancreatic beta-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study. 
  • Panel of biomarkers predicts stroke. 
  • Paradoxical Motor Recovery From a First Stroke After Induction of a Second Stroke: Reopening a Postischemic Sensitive Period. 
  • Parenthood and the risk of cardiovascular diseases among 0.5 million men and women: findings from the China Kadoorie Biobank. 
  • Parenting after stroke: a systematic review. 
  • Participant Outcomes of a Student-Run, Intensive, Short-Term, Task-Specific Rehabilitation Program for Individuals Post-Stroke. 
  • Patent foramen ovale in adults with sickle cell disease and stroke. 
  • Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach. 
  • Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface. 
  • Patient safety in trials of therapy for acute ischemic stroke. 
  • Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care. 
  • Patient-Reported Outcome Measures (PROMs) for Acute Stroke: Rationale, Methods and Future Directions. 
  • Patients living in impoverished areas have more severe ischemic strokes. 
  • Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. 
  • Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. 
  • Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. 
  • Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation. 
  • Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation. 
  • Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors. 
  • Patterns of care for first-detected atrial fibrillation: Insights from the Get With The Guidelines® - Atrial Fibrillation registry. 
  • Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease. 
  • Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With the Guidelines-Stroke. 
  • Patterns of infarction in hemodynamic failure. 
  • Patterns of oral anticoagulation use with cardioversion in clinical practice. 
  • Peak Systolic Velocity Measurements with Transcranial Doppler Ultrasound Is a Predictor of Incident Stroke among the General Population in China. 
  • Pearls & Oy-sters: multiple ischemic strokes secondary to heparin-induced thrombocytopenia. 
  • Pearls & Oy-sters: polycythemia vera presenting with ischemic strokes in multiple arterial territories. 
  • Penumbra Consumption Rates Based on Time-to-Maximum Delay and Reperfusion Status: A Post Hoc Analysis of the DEFUSE 3 Trial. 
  • Perceived Discrimination and Cardiovascular Outcomes in Older African Americans: Insights From the Jackson Heart Study. 
  • Perceived and actual stroke risk among men with hypertension. 
  • Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke. 
  • Perceptions of Stroke and Associated Health-Care-Seeking Behavior in Northern Tanzania: A Community-Based Study. 
  • Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. 
  • Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. 
  • Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management. 
  • Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation. 
  • Performance of a mail-administered version of a stroke-specific outcome measure, the Stroke Impact Scale. 
  • Perfusion CT with iodinated contrast material. 
  • Perfusion imaging and recurrent cerebrovascular events in intracranial atherosclerotic disease or carotid occlusion. 
  • Peri-procedural stroke or death in stenting of symptomatic severe intracranial stenosis. 
  • Perioperative hypertensive emergencies. 
  • Perioperative stroke: where do we go from here? 
  • Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. 
  • Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry. 
  • Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. 
  • Periprocedural complication rates are equivalent between symptomatic and asymptomatic patients undergoing carotid angioplasty and stenting. 
  • Personalized Reminders Increase Screening for Stroke Risk in Children with Sickle Cell Anemia. 
  • Pharmacoeconomics of atrial fibrillation and stroke prevention. 
  • Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. 
  • Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF. 
  • Pharmacotherapy in stroke rehabilitation. 
  • Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease. 
  • Physical and Family History Variables Associated With Neurological and Cognitive Development in Sturge-Weber Syndrome. 
  • Physician knowledge and practices in the evaluation of coagulopathies in stroke patients. 
  • Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). 
  • Plasma proteomics of patients with non-valvular atrial fibrillation on chronic anti-coagulation with warfarin or a direct factor Xa inhibitor. 
  • Platelet Counts and Postoperative Stroke After Coronary Artery Bypass Grafting Surgery. 
  • Platelet RNA as a novel biomarker for the response to antiplatelet therapy. 
  • Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study. 
  • Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. 
  • Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality. 
  • Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial. 
  • Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation. 
  • Polypill Trials for Stroke Prevention-Main Results, Critical Appraisal, and Implications for US Population. 
  • Poor performance of stroke prognostication using Age and National Institutes of Health Stroke Scale-100 to predict 3- and 12-month outcomes of ischemic stroke in China National Stroke Registry. 
  • Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults. 
  • Post-ischemia common carotid artery occlusion worsens memory loss, but not sensorimotor deficits, in long-term survived stroke mice. 
  • Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. 
  • Post-stroke patients with moderate function have the greatest risk of falls: a National Cohort Study. 
  • Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. 
  • Poststroke activity engagement in community dwellers: Association with illness perceptions and perceived environment. 
  • Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. 
  • Poststroke hypertension in Africa. 
  • Poststroke pharmacotherapy: another ictus. 
  • Poststroke treatment: lost in translation. 
  • Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial. 
  • Practical injection-rate CT perfusion imaging: deconvolution-derived hemodynamics in a case of stroke. 
  • Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation. 
  • Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database. 
  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. 
  • Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. 
  • Pre-Diabetes and Stroke in Patients With Atrial Fibrillation: When Risk Begets Risk. 
  • Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. 
  • Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review. 
  • Predicting aspiration in patients with ischemic stroke: comparison of clinical signs and aerodynamic measures of voluntary cough. 
  • Predicting symptomatic intracranial haemorrhage after mechanical thrombectomy: the TAG score. 
  • Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer. 
  • Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. 
  • Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. 
  • Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups. 
  • Predictors of 30-day postoperative stroke or death after carotid endarterectomy using the 2012 carotid endarterectomy-targeted American College of Surgeons National Surgical Quality Improvement Program database. 
  • Predictors of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: A Prespecified Secondary Analysis of the STROKE AF Randomized Clinical Trial. 
  • Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial. 
  • Predictors of Stroke, Myocardial Infarction or Death within 30 Days of Carotid Artery Stenting: Results from the International Carotid Stenting Study. 
  • Predictors of contemporary coronary artery bypass grafting outcomes. 
  • Predictors of hospital readmission after stroke: a systematic review. 
  • Predictors of long-term clinical endpoints in patients with refractory angina. 
  • Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial. 
  • Predictors of rapid brain imaging in acute stroke: analysis of the Get With the Guidelines-Stroke program. 
  • Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial. 
  • Predictors of stroke in patients paced for sick sinus syndrome. 
  • Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. 
  • Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. 
  • Predictors of symptomatic intracranial haemorrhage in patients with an ischaemic stroke with neurological deterioration after intravenous thrombolysis. 
  • Predictors of vertigo in the emergency department: The preved study. 
  • Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry. 
  • Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke. 
  • Pregnancy, pregnancy loss, and the risk of cardiovascular disease in Chinese women: findings from the China Kadoorie Biobank. 
  • Prehospital notification by emergency medical services reduces delays in stroke evaluation: findings from the North Carolina stroke care collaborative. 
  • Preoperative β-blocker use in coronary artery bypass grafting surgery: national database analysis. 
  • Preservation of structural brain network hubs is associated with less severe post-stroke aphasia. 
  • Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions. 
  • Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort. 
  • Prevalence and Associations of Retinal Emboli With Ethnicity, Stroke, and Renal Disease in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Disease Study. 
  • Prevalence and Prognostic Significance of Left Ventricular Noncompaction in Patients Referred for Cardiac Magnetic Resonance Imaging. 
  • Prevalence and clinical correlates of neuropsychiatric symptoms in dementia. 
  • Prevalence and correlates of cardiometabolic multimorbidity among hypertensive individuals: a cross-sectional study in rural South Asia-Bangladesh, Pakistan and Sri Lanka. 
  • Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival. 
  • Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus. 
  • Prevalence and risk factors of retinal arteriolar emboli: the Singapore Malay Eye Study. 
  • Prevalence of apparent treatment-resistant hypertension among individuals with CKD. 
  • Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting. 
  • Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation). 
  • Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. 
  • Preventable readmissions within 30 days of ischemic stroke among Medicare beneficiaries. 
  • Preventing Stroke in Patients With Atrial Fibrillation-A Steep Climb Away From Achieving Peak Performance. 
  • Prevention and health services delivery. 
  • Prevention and health services delivery. 
  • Prevention and health services delivery. 
  • Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). 
  • Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. 
  • Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association. 
  • Primary and key secondary results from the ROCKET AF trial, and their implications on clinical practice. 
  • Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. 
  • Primary prevention and health services delivery. 
  • Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. 
  • Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. 
  • Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. 
  • Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke. 
  • Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. 
  • Progestin-only contraception and thromboembolism: A systematic review. 
  • Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation. 
  • Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. 
  • Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death. 
  • Program for the epidemiological evaluation of stroke in Tandil, Argentina (PREVISTA) study: rationale and design. 
  • Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation. 
  • Prolonged Cardiac Monitoring and Stroke Recurrence: A Meta-analysis. 
  • Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. 
  • Prolonged Periods of Antegrade Cerebral Perfusion Are Safe During Elective Arch Surgery. 
  • Promise of factor Xa inhibition in atrial fibrillation. 
  • Proposed high-risk screening protocol for Fabry disease in patients with renal and vascular disease. 
  • Prosopometamorphopsia secondary to a left splenium of the corpus callosum infarct. 
  • Prospective acute ischemic stroke outcomes after endovascular therapy: a real-world experience. 
  • Protecting the brain in coronary artery bypass graft surgery. 
  • Protocol for a feasibility randomised controlled trial of Screening and Enhanced Risk management for Vascular Event-related Decline in Memory (SERVED Memory). 
  • Proximal embolic protection versus distal filter protection versus combined protection in carotid artery stenting: A systematic review and meta-analysis. 
  • Psychiatric sequelae of stroke affecting the non-dominant cerebral hemisphere. 
  • Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease. 
  • Pulmonary artery pulsatility index as a predictor of right ventricular failure in left ventricular assist device recipients: A systematic review. 
  • Pulse pressure and vascular risk in the elderly: associations and clinical implications. 
  • Putting risk prediction in atrial fibrillation into perspective. 
  • Quality Enhancement Research Initiative in stroke: prevention, treatment, and rehabilitation. 
  • Quality of Care and Ischemic Stroke Risk After Hospitalization for Transient Ischemic Attack: Findings From Get With The Guidelines-Stroke. 
  • Quality of Care and Outcomes for Patients With Stroke in the United States Admitted During the International Stroke Conference. 
  • Quality of Care for Veterans With Transient Ischemic Attack and Minor Stroke. 
  • Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry. 
  • Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. 
  • Quality of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation in the community setting. 
  • Quality of care and outcomes for in-hospital ischemic stroke: findings from the National Get With The Guidelines-Stroke. 
  • Quality of care for atrial fibrillation among patients hospitalized for heart failure. 
  • Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care. 
  • Quantification of whole-brain oxygenation extraction fraction and cerebral metabolic rate of oxygen consumption in adults with sickle cell anemia using individual T2 -based oxygenation calibrations. 
  • Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2. 
  • Question Use in Adults With Right-Hemisphere Brain Damage. 
  • RE: Cerebral air embolism following removal of central venous catheter, published in [Mil Med 2009: 174(8): 878-81]. 
  • RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome. 
  • Race-Ethnic Disparities in Rates of Declination of Thrombolysis for Stroke. 
  • Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy. 
  • Racial Differences in Neurocognitive Outcomes Post-Stroke: The Impact of Healthcare Variables. 
  • Racial and ethnic differences in outcomes in older patients with acute ischemic stroke. 
  • Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review. 
  • Racial differences in mortality among patients with acute ischemic stroke: an observational study. 
  • Racial differences in persistence to secondary prevention medication regimens after ischemic stroke. 
  • Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease. 
  • Racial inequity of access to carotid imaging. 
  • Racial variation in initial stroke severity. 
  • Racial variations in postoperative outcomes of carotid endarterectomy: evidence from the Veterans Affairs National Surgical Quality Improvement Program. 
  • Racial/Ethnic and Sex Differences in Emergency Medical Services Transport Among Hospitalized US Stroke Patients: Analysis of the National Get With The Guidelines-Stroke Registry. 
  • Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry. 
  • Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials. 
  • Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway. 
  • Randomized Pragmatic Trial of Stroke Transitional Care: The COMPASS Study. 
  • Randomized Sham-Controlled Trial of Navigated Repetitive Transcranial Magnetic Stimulation for Motor Recovery in Stroke. 
  • Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. 
  • Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. 
  • Rapid change in prescribing behavior in hospitals participating in get with the guidelines-stroke after release of the management of atherothrombosis with clopidogrel in high-risk patients (MATCH) clinical trial results. 
  • Rates, Characteristics, and Outcomes of Patients Transferred to Specialized Stroke Centers for Advanced Care. 
  • Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. 
  • Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation. 
  • Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction. 
  • Rationale and design of a cluster-randomized multifaceted intervention trial to improve stroke care quality in China: The GOLDEN BRIDGE-Acute Ischemic Stroke. 
  • Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China. 
  • Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction. 
  • Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease. 
  • Re: Stages and thresholds of hemodynamic failure. 
  • Re: Stroke in sub-Saharan Africa: an urgent call for prevention. 
  • Reader response: Optimizing in-hospital triage for large vessel occlusion using a novel clinical scale (GAI2AA). 
  • Reader response: The dimension of preventable stroke in a large representative patient cohort. 
  • Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study. 
  • Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy. 
  • Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants and Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase-Reply. 
  • Recent developments regarding human immunodeficiency virus infection and stroke. 
  • Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke. 
  • Recommendations for clinical trial evaluation of acute stroke therapies. 
  • Recommendations for improving the quality of care through stroke centers and systems: an examination of stroke center identification options: multidisciplinary consensus recommendations from the Advisory Working Group on Stroke Center Identification Options of the American Stroke Association. 
  • Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. 
  • Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. 
  • Recommendations from the international stroke genetics consortium, part 2: biological sample collection and storage. 
  • Recovery and survival from aging-associated diseases. 
  • Recovery experiences of younger stroke survivors who are parents: A qualitative content analysis. 
  • Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. 
  • Recurrent Hemispheric Stroke Syndromes in Symptomatic Atherosclerotic Internal Carotid Artery Occlusions: The Carotid Occlusion Surgery Study Randomized Trial. 
  • Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study. 
  • Recurrent expressive aphasia as a presentation of cat-scratch encephalopathy. 
  • Redefining Early Neurological Improvement After Reperfusion Therapy in Stroke. 
  • Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. 
  • ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor. 
  • Reducing death and disability from stroke: the role of governmental advocacy. 
  • Reduction in blood pressure for elevated blood pressure/stage 1 hypertension according to the American College of Cardiology/American Heart Association guideline and cardiovascular outcomes. 
  • Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER. 
  • Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients. 
  • Regarding "stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria". 
  • Regional Variation in 30-Day Ischemic Stroke Outcomes for Medicare Beneficiaries Treated in Get With The Guidelines-Stroke Hospitals. 
  • Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF). 
  • Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial. 
  • Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010. 
  • Regional versus general anesthesia for carotid endarterectomy: the American College of Surgeons National Surgical Quality Improvement Program perspective. 
  • Regulatory device approval for stroke: fair and balanced? 
  • Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial). 
  • Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial). 
  • Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years. 
  • Relationship Between Dual-Task Gait Speed and Walking Activity Poststroke. 
  • Relationship between hospital performance measures and outcomes in patients with acute ischaemic stroke: a prospective cohort study. 
  • Relationship between race and mortality and morbidity after valve replacement surgery. 
  • Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial. 
  • Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial. 
  • Relationships between gait variability and ambulatory activity post stroke. 
  • Relative Mean Transit Time Predicts Subsequent Stroke in Symptomatic Carotid Occlusion. 
  • Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. 
  • Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. 
  • Religion and medicine IV: religion, physical health, and clinical implications. 
  • Renal Dysfunction Is Associated With Poststroke Discharge Disposition and In-Hospital Mortality: Findings From Get With The Guidelines-Stroke. 
  • Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. 
  • Renal function, atherothrombosis extent, and outcomes in high-risk patients. 
  • Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. 
  • Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time. 
  • Reperfusion Beyond 6 Hours Reduces Infarct Probability in Moderately Ischemic Brain Tissue. 
  • Reply to Tleyjeh and Baddour. 
  • Reply to effect of CYP2C19*2 and *3 on clinical outcome in ischemic stroke patients treated with Clopidogrel. 
  • Reply to: Among patients with MINOCA women versus men have the increased risks of MACE and stroke? 
  • Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. 
  • Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection. 
  • Representativeness of the Get With The Guidelines-Stroke Registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke. 
  • Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. 
  • Research without borders: fostering innovative clinical research and implementation. 
  • Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. 
  • Response and prediction of improvement in gait speed from functional electrical stimulation in persons with poststroke drop foot. 
  • Response by Ehrlich et al to Letter Regarding Article, "Safety of Computed Tomographic Angiography in the Evaluation of Patients With Acute Stroke: A Single-Center Experience". 
  • Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF". 
  • Response by Mac Grory and Yaghi to Letter Regarding Article, "SARS-CoV-2 and Stroke in a New York Healthcare System". 
  • Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". 
  • Response by Powers and Rabinstein to Letter Regarding Article, "2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". 
  • Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans". 
  • Response to Letter Regarding Article, "Endovascular Thrombectomy for Anterior Circulation Stroke: Systematic Review and Meta-Analysis". 
  • Response to Letter to the Editor regarding "Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization". 
  • Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". 
  • Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials". 
  • Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts". 
  • Responses to the 10 most frequently asked questions about perfusion CT. 
  • Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial. 
  • Results of a reevaluation of cardiovascular outcomes in the RECORD trial. 
  • Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. 
  • Results with an algorithmic approach to hybrid repair of the aortic arch. 
  • Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. 
  • Retinal fractals and acute lacunar stroke. 
  • Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. 
  • Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. 
  • Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. 
  • Retinal microvascular changes and risk of stroke: the Singapore Malay Eye Study. 
  • Retinal microvascular changes and subsequent vascular events after ischemic stroke. 
  • Retinal microvascular signs and risk of stroke and stroke mortality. 
  • Retinal microvascular signs and risk of stroke: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Retinal microvascular signs may provide clues to the underlying vasculopathy in patients with deep intracerebral hemorrhage. 
  • Retinal signs and stroke: revisiting the link between the eye and brain. 
  • Retinal vascular caliber and extracranial carotid disease in patients with acute ischemic stroke: the Multi-Centre Retinal Stroke (MCRS) study. 
  • Retinal vascular caliber as a biomarker for diabetes microvascular complications. 
  • Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
  • Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. 
  • Retinopathy and lobar intracerebral hemorrhage: insights into pathogenesis. 
  • Retrospective analysis of bovine pericardium (Vascu-Guard) for patch closure in carotid endarterectomies. 
  • Retrospective assessment of initial stroke severity: comparison of the NIH Stroke Scale and the Canadian Neurological Scale. 
  • Revisiting flow augmentation bypass for cerebrovascular atherosclerotic vaso-occlusive disease: Single-surgeon series and review of the literature. 
  • Rhythm control in atrial fibrillation. 
  • Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease. 
  • Risk Factors Associated With Mortality and Neurologic Disability After Intracerebral Hemorrhage in a Racially and Ethnically Diverse Cohort. 
  • Risk Factors For Stroke, Myocardial Infarction, or Death Following Carotid Endarterectomy: Results From the International Carotid Stenting Study. 
  • Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention. 
  • Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation. 
  • Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan　- Insights From GARFIELD-AF. 
  • Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association. 
  • Risk assessment in atrial fibrillation: not all factors are created equal. 
  • Risk assessment to predict arterial and venous events in patients undergoing percutaneous coronary intervention. 
  • Risk factor profile and management of cerebrovascular patients in the REACH Registry. 
  • Risk factors for cerebrovascular events following fontan palliation in patients with a functional single ventricle. 
  • Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial). 
  • Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry. 
  • Risk factors for stroke on left ventricular assist devices. 
  • Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rate. 
  • Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. 
  • Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. 
  • Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. 
  • Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials. 
  • Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. 
  • Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). 
  • Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. 
  • Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. 
  • Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. 
  • Risk stratification for stroke in atrial fibrillation: a critique. 
  • Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS. 
  • Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator. 
  • Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. 
  • Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. 
  • Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. 
  • Risks of stroke and current indications for cerebral revascularization in patients with carotid occlusion. 
  • Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. 
  • Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial. 
  • Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. 
  • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. 
  • Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF. 
  • Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. 
  • Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. 
  • Rivaroxaban, an oral direct factor Xa inhibitor. 
  • Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. 
  • Road mapping ATLAS ACS 2: are we there yet? 
  • Role of caregiver factors in outpatient medical follow-up post-stroke: observational study in Singapore. 
  • Routine 24-Hour Computed Tomography Brain Scan is not useful in stable patients Post Intravenous Tissue Plasminogen Activator. 
  • Rural Residence and Antihypertensive Medication Use in US Stroke Survivors. 
  • SARS-CoV-2 and Stroke in a New York Healthcare System. 
  • SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure. 
  • STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. 
  • SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases. 
  • SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation in Patients With Atrial Fibrillation. 
  • Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials. 
  • Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial. 
  • Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke. 
  • Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis. 
  • Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes. 
  • Safety and tolerability of transcranial direct current stimulation to stroke patients - A phase I current escalation study. 
  • Safety of Computed Tomographic Angiography in the Evaluation of Patients With Acute Stroke: A Single-Center Experience. 
  • Safety of abciximab administration during PCI of patients with previous stroke. 
  • Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). 
  • Scratching after Stroking and Poking: A Spinal Circuit Underlying Mechanical Itch. 
  • Screening for Atrial Fibrillation With a Wearable Device. 
  • Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. 
  • Screening for Hypertension and Lowering Blood Pressure for Prevention of Cardiovascular Disease Events. 
  • Screening for asymptomatic carotid artery stenosis: caveat emptor. 
  • Screening for hypercoagulable syndromes following stroke. 
  • Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood. 
  • Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation. 
  • Screening with MRI for Accurate and Rapid Stroke Treatment: SMART. 
  • Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. 
  • Seasonal variation in 30-day mortality after stroke: teaching versus nonteaching hospitals. 
  • Secondary prevention of ischaemic stroke: more evidence to block two pathways affecting platelet activation. 
  • Secondary preventive medication persistence and adherence 1 year after stroke. 
  • Secondary stroke prevention strategies for the oldest patients: possibilities and challenges. 
  • Secondhand smoke exposure is associated with abnormal P-wave axis. 
  • Seizures and epilepsy after ischemic stroke. 
  • Selection of Postacute Stroke Rehabilitation Facilities: A Survey of Discharge Planners From the Northeast Cerebrovascular Consortium (NECC) Region. 
  • Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry-Get With the Guidelines. 
  • Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. 
  • Selective versus routine intraoperative shunting during carotid endarterectomy: a multivariate outcome analysis. 
  • Self- or proxy-reported stroke and the risk of Alzheimer disease. 
  • Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease. 
  • Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery. 
  • Semiquantitative assessed proteinuria and risk of heart failure: analysis of a nationwide epidemiological database. 
  • Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. 
  • Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials. 
  • Serum Troponin Level in Acute Ischemic Stroke Identifies Patients with Visceral Infarcts. 
  • Serum alpha-1 antitrypsin in acute ischemic stroke: A prospective pilot study. 
  • Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction. 
  • Serum fatty acids and incidence of ischemic stroke among postmenopausal women. 
  • Serum homocysteine and stroke in atrial fibrillation. 
  • Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study. 
  • Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. 
  • Sex Differences in Endovascular Therapy for Ischemic Stroke: Results From the Get With The Guidelines-Stroke Registry. 
  • Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry. 
  • Sex and Age Interactions and Differences in Outcomes After Intracerebral Hemorrhage. 
  • Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5. 
  • Sex differences in neurological outcomes and mortality after cardiac surgery: a society of thoracic surgery national database report. 
  • Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. 
  • Sex differences in quality of life after ischemic stroke. 
  • Sex-Based Differences in Outcomes After Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation: From the Cardiothoracic Surgical Trials Network. 
  • Sex-Differences in Cause of Death for Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction (from the ASCEND-HF Trial). 
  • Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis. 
  • Sex-related differences in outcomes after coronary artery bypass surgery-A patient-level pooled analysis of randomized controlled trials: rationale and study protocol. 
  • Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions. 
  • Shock Index Predicts Patient-Related Clinical Outcomes in Stroke. 
  • Short-Term Trajectories of Depressive Symptoms in Stroke Survivors and Their Family Caregivers. 
  • Should We Perform Carotid Doppler Screening Before Surgical or Transcatheter Aortic Valve Replacement? 
  • Should antihypertensive therapies be given to patients with acute ischemic stroke? 
  • Should patients on vitamin K antagonists be treated differently? 
  • Should we cross the valve: the risk of retrograde catheterization of the left ventricle in patients with aortic stenosis. 
  • Sibling history of myocardial infarction or stroke and risk of cardiovascular disease in the elderly: the Cardiovascular Health Study. 
  • Sickle cell disease. 
  • Signal evolution and infarction risk for apparent diffusion coefficient lesions in acute ischemic stroke are both time- and perfusion-dependent. 
  • Similar secondary stroke prevention and medication persistence rates among rural and urban patients. 
  • Simulation of Daily Snapshot Rhythm Monitoring to Identify Atrial Fibrillation in Continuously Monitored Patients with Stroke Risk Factors. 
  • Single-cell transcriptomic analysis of the immune cell landscape in the aged mouse brain after ischemic stroke. 
  • Skilled Nursing and Inpatient Rehabilitation Facility Use by Medicare Fee-for-Service Beneficiaries Discharged Home After a Stroke: Findings From the COMPASS Trial. 
  • Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways. 
  • Smoking Paradox in Patients Hospitalized With Coronary Artery Disease or Acute Ischemic Stroke: Findings From Get With The Guidelines. 
  • Smoking and ischemic stroke: a role for nicotine? 
  • Smoothened is a therapeutic target for reducing glutamate toxicity in ischemic stroke. 
  • Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study. 
  • Socio-ecological perspective on factors influencing acute recovery of younger stroke survivors: A mixed methods study. 
  • Something Is Better Than Nothing: The Value of Active Intervention in Stated Preferences for Treatments to Delay Onset of Alzheimer's Disease Symptoms. 
  • Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy. 
  • Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. 
  • Statewide assessment of hospital-based stroke prevention and treatment services in North Carolina: changes over the last 5 years. 
  • Statewide hospital-based stroke services in North Carolina: changes over 10 years. 
  • Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke. 
  • Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Statin use and sex-specific stroke outcomes in patients with vascular disease. 
  • Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). 
  • Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease. 
  • Statins and ischemic stroke severity: cytoprotection. 
  • Statins and poststroke intracerebral hemorrhage: Concern but increasing reassurance. 
  • Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack. 
  • Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. 
  • Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out. 
  • Statins for stroke prevention. 
  • Stem cells in the treatment of stroke. 
  • Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis. 
  • Stoichiometric Post-Modification of Hydrogel Microparticles Dictates Neural Stem Cell Fate in Microporous Annealed Particle Scaffolds. 
  • Strategic planning to reduce the burden of stroke among veterans: using simulation modeling to inform decision making. 
  • Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. 
  • Stroke Care Costs and Cost-Effectiveness to Inform Health Policy. 
  • Stroke Care during the COVID-19 Pandemic: International Expert Panel Review. 
  • Stroke Learning Health Systems: A Topical Narrative Review With Case Examples. 
  • Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial. 
  • Stroke Prediction in Atrial Fibrillation: Is it Black and White? 
  • Stroke Prevention in Patients with Patent Foramen Ovale. 
  • Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee. 
  • Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications. 
  • Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA₂ DS₂ -VASc Scores: Findings From the ORBIT-AF I and II Registries. 
  • Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. 
  • Stroke after Thoracic Endovascular Aortic Aneurysm Repair: A Silent Enemy that Needs More Caution. 
  • Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes. 
  • Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement. 
  • Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy. 
  • Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. 
  • Stroke care quality in China: Substantial improvement, and a huge challenge and opportunity. 
  • Stroke center designation can be achieved by small hospitals: the Massachusetts experience. 
  • Stroke code chest radiographs are not useful. 
  • Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study. 
  • Stroke in Patients With Peripheral Artery Disease. 
  • Stroke in patients with asymptomatic internal-carotid-artery stenosis. 
  • Stroke in young cannabis users (18-49 years): National trends in hospitalizations and outcomes. 
  • Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. 
  • Stroke of Known Cause and Underlying Atrial Fibrillation (STROKE-AF) randomized trial: Design and rationale. 
  • Stroke patient outcomes in US hospitals before the start of the Joint Commission Primary Stroke Center certification program. 
  • Stroke prevention in atrial fibrillation. 
  • Stroke prevention in atrial fibrillation: Closing the gap. 
  • Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe. 
  • Stroke prevention in patients with atrial fibrillation: disease burden and unmet medical needs. 
  • Stroke recovery and rehabilitation. 
  • Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy. 
  • Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices. 
  • Stroke survivors' preferences for post-stroke self-management programs: A discrete choice experiment. 
  • Stroke-related knowledge among uninsured Latino immigrants in Durham County, North Carolina. 
  • Stroke: Misery perfusion in cerebrovascular disease--is it important? 
  • Stroke: Organizing the disorganized: improving TIA patient care. 
  • Stroke: working toward a prioritized world agenda. 
  • Stroke: working toward a prioritized world agenda. 
  • Stroke: working toward a prioritized world agenda. 
  • Strokelore: Antithrombotic therapy and hemorrhagic infarction. 
  • Strokelore: Outcome of Basilar Artery Occlusion. 
  • Strokelore: Therapeutic Relevance of Lacunar Infarcts. 
  • Study protocol: home-based telehealth stroke care: a randomized trial for veterans. 
  • Substantial Progress Yet Significant Opportunity for Improvement in Stroke Care in China. 
  • Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. 
  • Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. 
  • Surgical ablation of atrial fibrillation trends and outcomes in North America. 
  • Surgical results of the Carotid Occlusion Surgery Study. 
  • Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT. 
  • Symbiotic relationship of IV-tPA and mechanical thrombectomy in a case of acute tandem ICA-MCA occlusion. 
  • Symptomatic autoregulatory failure in acute ischemic stroke. 
  • Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients. 
  • System-integrated technology-enabled model of care (SINEMA) to improve the health of stroke patients in rural China: Statistical analysis plan for a cluster-randomized controlled trial. 
  • System-integrated technology-enabled model of care to improve the health of stroke patients in rural China: protocol for SINEMA-a cluster-randomized controlled trial. 
  • Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain 
  • Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke. 
  • Targeting telestroke: benchmarking time performance in telestroke consultations. 
  • Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report. 
  • Temperature and Precipitation Associate With Ischemic Stroke Outcomes in the United States. 
  • Temporal Trends in Racial and Ethnic Disparities in Endovascular Therapy in Acute Ischemic Stroke. 
  • Temporal changes in the external validity of clinical trials: asymptomatic carotid artery stenosis. 
  • Temporal similarity perfusion mapping: A standardized and model-free method for detecting perfusion deficits in stroke. 
  • Temporal trends and rural-urban disparities in cerebrovascular risk factors, in-hospital management and outcomes in ischaemic strokes in China from 2005 to 2015: a nationwide serial cross-sectional survey. 
  • Temporary endovascular bypass: a novel treatment for acute stroke. 
  • Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials. 
  • Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial. 
  • Testing a test: a report card for DWI in acute stroke. 
  • Testing the Presumption of Consent to Emergency Treatment for Acute Ischemic Stroke 
  • Thalamic control of human attention driven by memory and learning. 
  • The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. 
  • The 2009 Feinberg lecture: the continuum of stroke research and policy. 
  • The 2021 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, April 21, 2021. 
  • The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. 
  • The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults. 
  • The Addition of Atrial Fibrillation to the Los Angeles Motor Scale May Improve Prediction of Large Vessel Occlusion. 
  • The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. 
  • The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts. 
  • The Association of Kidney Function and Albuminuria With the Risk and Outcomes of Syncope: A Population-Based Cohort Study. 
  • The Burden of Hypertension and Diabetes in an Emergency Department in Northern Tanzania. 
  • The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trial. 
  • The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry. 
  • The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association. 
  • The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. 
  • The Implementation of a Primary Care-Based Integrated Mobile Health Intervention for Stroke Management in Rural China: Mixed-Methods Process Evaluation. 
  • The Incidence and Natural Progression of New-Onset Postoperative Atrial Fibrillation. 
  • The Medicare Shared Savings Program and Outcomes for Ischemic Stroke Patients: a Retrospective Cohort Study. 
  • The National Physical Activity Plan: a call to action from the American Heart Association: a science advisory from the American Heart Association. 
  • The Need for Speed. 
  • The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES). 
  • The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. 
  • The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial. 
  • The Risk of Stroke on Left Ventricular Assist Device Support: Steady Gains or Stalled Progress? 
  • The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. 
  • The Weekend Effect in Carotid Endarterectomy for Symptomatic Carotid Stenosis. 
  • The alphabet soup of perfusion CT and MR imaging: terminology revisited and clarified in five questions. 
  • The antiphospholipid syndrome: what are we really measuring? How do we measure it? And how do we treat it? 
  • The association between fluid balance and outcomes after subarachnoid hemorrhage. 
  • The association between socioeconomic status and disability after stroke: findings from the Adherence eValuation After Ischemic stroke Longitudinal (AVAIL) registry. 
  • The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative. 
  • The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease. 
  • The association of marital/partner status with patient-reported health outcomes following acute myocardial infarction or stroke: Protocol for a systematic review and meta-analysis. 
  • The associations between caregivers' psychosocial characteristics and caregivers' depressive symptoms in stroke settings: a cohort study. 
  • The atrial FibriLlatiOn real World management registry in the Middle East and Africa: design and rationale. 
  • The bispectral index in the diagnosis of perioperative stroke: a case report and discussion. 
  • The cart and the horse: the advancing technology of carotid artery stenting. 
  • The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. 
  • The development and potential of acoustic radiation force impulse (ARFI) imaging for carotid artery plaque characterization. 
  • The economic burden of chronic cardiovascular disease for major insurers. 
  • The effect of poststroke cognitive impairment on rehabilitation process and functional outcome. 
  • The effect of statin use and intensity on stroke and myocardial infarction after carotid endarterectomy. 
  • The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). 
  • The effectiveness of personalized coronary heart disease and stroke risk communication. 
  • The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • The efficacy of treadmill training on balance dysfunction in individuals with chronic stroke: a systematic review. 
  • The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease. 
  • The excess burden of stroke in hospitalized adults with sickle cell disease. 
  • The feasibility and effectiveness of using prism adaptation to treat motor and spatial dysfunction in stroke survivors with multiple incidents of stroke. 
  • The hazards of stroke case selection using administrative data. 
  • The healthy diver: A cross-sectional survey to evaluate the health status of recreational scuba diver members of Divers Alert Network (DAN). 
  • The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. 
  • The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. 
  • The impact of intraoperative shunting on early neurologic outcomes after carotid endarterectomy. 
  • The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism. 
  • The impact of stroke on psychological and physical function outcomes in people with long-term physical disability. 
  • The impact of the implementation of a mobile stroke unit on a stroke cohort. 
  • The importance of factor Xa regulatory pathways in vascular thromboresistance: focus on protein Z. 
  • The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registries. 
  • The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War? 
  • The left atrial appendage morphology is associated with embolic stroke subtypes using a simple classification system: A proof of concept study. 
  • The network of Shanghai Stroke Service System (4S): A public health-care web-based database using automatic extraction of electronic medical records. 
  • The new standing guideline committee policy of the American Stroke Association Stroke Council. 
  • The next generation: the need to expand upon traditional risk factors for stroke. 
  • The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. 
  • The pharmacogenetics of coumarin therapy. 
  • The pharmacology of novel oral anticoagulants. 
  • The prepuce as a donor site for reconstruction of an extravasation injury to the foot in a newborn. 
  • The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. 
  • The relationship between aortic stiffness and changes in retinal microvessels among Asian ischemic stroke patients. 
  • The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events. 
  • The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). 
  • The relationship between the morning blood pressure surge and low-grade inflammation on silent cerebral infarct and clinical stroke events. 
  • The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement. 
  • The risk of stroke and death in patients with aortic and mitral valve endocarditis. 
  • The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. 
  • The role of aspirin in cardiovascular diseases--forgotten benefits? 
  • The role of conflict, feedback, and action comprehension in monitoring of action errors: Evidence for internal and external routes. 
  • The role of evidence reports in evidence-based medicine: a mechanism for linking scientific evidence and practice improvement. 
  • The role of neuroendocrine pathways in prognosis after stroke. 
  • The role of panoramic radiographs in the medical surveillance of a patient at risk for stroke: case report. 
  • The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. 
  • The safety of aeroplane travel in patients with symptomatic carotid occlusion. 
  • The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. 
  • The spectrum of complications following left ventricular assist device placement. 
  • The stroke that struck back: an unusual alien hand presentation. 
  • The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. 
  • The use of positron emission tomography in cerebrovascular disease. 
  • Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry. 
  • Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. 
  • Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). 
  • Thromboelastography detects inadequate response to abciximab therapy during stent-assisted cerebral aneurysm coil embolization complicated by stroke. 
  • Thrombolysis for acute ischemic stroke in patients with cancer: a population study. 
  • Thrombolysis in stroke: a medicolegal quagmire. 
  • Thrombolysis in young adults with acute ischemic stroke: Quicker may be better. 
  • Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke. 
  • Thrombolysis is an Independent Risk Factor for Poor Outcome After Carotid Revascularization. 
  • Thrombolytic therapy for wake-up stroke: A systematic review and meta-analysis. 
  • Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. 
  • Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE Study. 
  • Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. 
  • Thrombus on the inflow cannula of the HeartWare HVAD: an update. 
  • Thromobolysis for acute ischemic stroke: is intra-arterial better than intravenous? A treatment effects model. 
  • Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial. 
  • Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. 
  • Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. 
  • Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials. 
  • Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack. 
  • Ticagrelor versus clopidogrel in patients with acute coronary syndromes. 
  • Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial. 
  • Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. 
  • Ticagrelor with or without Aspirin in High-Risk Patients after PCI. 
  • Time in Therapeutic Range Significantly Impacts Survival and Adverse Events in Destination Therapy Patients. 
  • Time to Endovascular Reperfusion and Outcome in Acute Ischemic Stroke : A Nationwide Prospective Registry in China. 
  • Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. 
  • Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial. 
  • Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. 
  • Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care. 
  • Times from symptom onset to hospital arrival in the Get with the Guidelines--Stroke Program 2002 to 2009: temporal trends and implications. 
  • Tissue plasminogen activator concentration dependence of 120 kHz ultrasound-enhanced thrombolysis. 
  • To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours. 
  • To bridge or not to bridge: these are the questions. 
  • Tobacco smoking in patients with heart failure and coronary artery disease: A 20-year experience at Duke University Medical Center. 
  • Today's Approach to Treating Brain Swelling in the Neuro Intensive Care Unit. 
  • Top Ten Tips Palliative Care Clinicians Should Know About Strokes. 
  • Total shoulder arthroplasty in patients with HIV infection: complications, comorbidities, and trends. 
  • Tracheostomy After Severe Acute Brain Injury: Trends and Variability in the USA. 
  • Traditional risk factors and combined genetic markers of recurrent ischemic stroke in adults: Comment from Wilson et al. 
  • Trajectories of positive aspects of caregiving among family caregivers of stroke-survivors: the differential impact of stroke-survivor disability. 
  • Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. 
  • Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. 
  • Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials. 
  • Transcatheter interventions across an inferior vena cava filter. 
  • Transcranial Direct Current Stimulation Post-Stroke Upper Extremity Motor Recovery Studies Exhibit a Dose-Response Relationship. 
  • Transcranial Doppler Ultrasound During Critical Illness in Children: Survey of Practices in Pediatric Neurocritical Care Centers. 
  • Transcriptome-Wide Analysis Identifies Novel Associations With Blood Pressure. 
  • Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. 
  • Transglutaminase 2 protects against ischemic stroke. 
  • Transient ischemic attack and acute ischemic stroke: associations with retinal microvascular signs. 
  • Transition of care for acute stroke and myocardial infarction patients: from hospitalization to rehabilitation, recovery, and secondary prevention. 
  • Transitional care after hospitalization for acute stroke or myocardial infarction: a systematic review. 
  • Translating evidence into practice: a decade of efforts by the American Heart Association/American Stroke Association to reduce death and disability due to stroke: a presidential advisory from the American Heart Association/American Stroke Association. 
  • Translational research in acute central nervous system injury: lessons learned and the future. 
  • Transradial access for carotid artery stenting: a single-center experience. 
  • Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation. 
  • Treating In-Hospital Stroke. 
  • Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit? 
  • Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis. 
  • Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack. 
  • Treatment Strategies for Deficiency of Adenosine Deaminase 2. 
  • Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population. 
  • Treatment crossovers did not affect randomized treatment comparisons in the Mode Selection Trial (MOST). 
  • Treatment of anemia with darbepoetin alfa in systolic heart failure. 
  • Treatment of arterial gas embolism. 
  • Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. 
  • Treatment of depression in the medically ill. 
  • Treatment of post-stroke depression with antidepressants. 
  • Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. 
  • Treatments-Preventive. 
  • Trends in 1-Year Recurrent Ischemic Stroke in the US Medicare Fee-for-Service Population. 
  • Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020. 
  • Trends in Use, Outcomes, and Disparities in Endovascular Thrombectomy in US Patients With Stroke Aged 80 Years and Older Compared With Younger Patients. 
  • Trends in endovascular therapy and clinical outcomes within the nationwide Get With The Guidelines-Stroke registry. 
  • Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018. 
  • Trends in one-year recurrent ischemic stroke among the elderly in the USA: 1994-2002. 
  • Trends in stroke mortality: the impact of the Year 2000 Age Standard and the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. 
  • Trends in survival and recovery from stroke: evidence from the National Long-Term Care Survey/Medicare data. 
  • Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. 
  • Trends in the use of feeding tubes in North Carolina hospitals. 
  • Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. 
  • Troponin Improves the Yield of Transthoracic Echocardiography in Ischemic Stroke Patients of Determined Stroke Subtype. 
  • Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. 
  • Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. 
  • Two-year outcomes after transcatheter or surgical aortic-valve replacement. 
  • Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries. 
  • US Surveillance of Acute Ischemic Stroke Patient Characteristics, Care Quality, and Outcomes for 2019. 
  • Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials. 
  • Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib). 
  • Unexplained Variation for Hospitals' Use of Inpatient Rehabilitation and Skilled Nursing Facilities After an Acute Ischemic Stroke. 
  • Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions? 
  • Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. 
  • Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. 
  • Urinary tract infection after stroke: A narrative review. 
  • Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age. 
  • Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation. 
  • Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation. 
  • Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry. 
  • Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial. 
  • Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke. 
  • Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke. 
  • Use of a Smartphone Platform to Help With Emergency Management of Acute Ischemic Stroke: Observational Study. 
  • Use of a vascular reconstruction device to salvage acute ischemic occlusions refractory to traditional endovascular recanalization methods. 
  • Use of antithrombotic medications among elderly ischemic stroke patients. 
  • Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial. 
  • Use of left atrial appendage occlusion among older cardiac surgery patients with preoperative atrial fibrillation: a national cohort study. 
  • Use of online promotion to encourage patient awareness of aspirin use to prevent heart attack and stroke. 
  • Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. 
  • Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke. 
  • Use of the ICD-10 vision codes to study ocular conditions in Medicare beneficiaries with stroke. 
  • Use, Temporal Trends, and Outcomes of Endovascular Therapy After Interhospital Transfer in the United States. 
  • Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction. 
  • Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation. 
  • Utility of Normalized Body Composition Areas, Derived From Outpatient Abdominal CT Using a Fully Automated Deep Learning Method, for Predicting Subsequent Cardiovascular Events. 
  • Utility of an obstacle-crossing test to classify future fallers and non-fallers at hospital discharge after stroke: A pilot study. 
  • Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation. 
  • Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? 
  • VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. 
  • VA Stroke Study: neurologist care is associated with increased testing but improved outcomes. 
  • Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial. 
  • Validation of Cardiovascular End Points Ascertainment Leveraging Multisource Electronic Health Records Harmonized Into a Common Data Model in the ADAPTABLE Randomized Clinical Trial. 
  • Validation of an item bank in a sample of community-dwelling survivors of a stroke. 
  • Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. 
  • Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT-AF II. 
  • Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. 
  • Variation and impact of polygenic hematologic traits in monogenic sickle cell disease. 
  • Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry. 
  • Vascular Cellular Adhesion Molecule-1 (VCAM-1) and Memory Impairment in African-Americans after Small Vessel-Type Stroke. 
  • Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. 
  • Venous thromboembolism in the Get With The Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis. 
  • Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. 
  • Very Early Constraint-Induced Movement during Stroke Rehabilitation (VECTORS): A single-center RCT. 
  • Veterans Administration Acute Stroke (VASt) Study: lack of race/ethnic-based differences in utilization of stroke-related procedures or services. 
  • Video training and certification program improves reliability of postischemic neurologic deficit measurement in the rat. 
  • Viral respiratory tract infections increase platelet reactivity and activation: an explanation for the higher rates of myocardial infarction and stroke during viral illness. 
  • Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study. 
  • Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study. 
  • Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial. 
  • Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). 
  • Vorapaxar in the secondary prevention of atherothrombosis. 
  • Vorapaxar in the secondary prevention of atherothrombotic events. 
  • Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. 
  • Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial. 
  • Warfarin for Atrial Fibrillation Stroke Prophylaxis in Advanced Kidney Disease: If You Are Not Confused, You Are Not Thinking Clearly. 
  • Warfarin or aspirin for recurrent ischemic stroke. 
  • Watchman device migration and embolization: A report from the NCDR LAAO Registry. 
  • Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database). 
  • Weighting composite endpoints in clinical trials: essential evidence for the heart team. 
  • What is the future of stroke prevention?: debate: polypill versus personalized risk factor modification. 
  • When Low-Risk Atrial Fibrillation Is Not So Low Risk: Beast of Burden. 
  • When and how to fix a 'hole in the heart': approach to ASD and PFO. 
  • Which stroke symptoms prompt a 911 call? A population-based study. 
  • Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. 
  • Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants? 
  • Will submandibular TCD prevent stroke in children with sickle cell anemia? 
  • William M. Feinberg award for excellence in clinical stroke: hemodynamics and stroke risk in carotid artery occlusion. 
  • Women's Health Initiative clinical trials: potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease. 
  • Working With Statisticians in Clinical Research. 
  • XBP1 (X-Box-Binding Protein-1)-Dependent O-GlcNAcylation Is Neuroprotective in Ischemic Stroke in Young Mice and Its Impairment in Aged Mice Is Rescued by Thiamet-G. 
  • Xenon neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage. 
  • [Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments]. 
  • [Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology]. 
  • [Neurology and cardiology: points of contact]. 
  • β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Bettger, Janet Prvu, Adjunct Associate in the Department of Orthopaedic Surgery, Duke Science & Society
  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • Ehrlich, Matthew Evan, Assistant Professor of Neurology, Hospital Neurology
  • Feld, Jody Ann, Assistant Professor in Orthopaedic Surgery, Orthopaedic Surgery, Physical Therapy
  • Feng, Wuwei, Professor of Neurology, Biomedical Engineering
  • Gold, Deborah T., Professor Emeritus in Psychiatry and Behavioral Sciences, Psychiatry, Child & Family Mental Health & Community Psychiatry
  • Granger, Christopher Bull, Professor of Medicine, School of Nursing
  • Hasan, David, Professor of Neurosurgery, Neurosurgery
  • James, Michael Lucas, Associate Professor of Anesthesiology, Anesthesiology
  • Kam, Wayneho, Assistant Professor of Neurology, Hospital Neurology
  • Le, Scott Mayhugh, Assistant Professor of Neurology, Neurology, Stroke and Vascular Neurology
  • Lusk, Jay, Affiliate, Medical Education
  • Mandge, Vishal A., Assistant Professor of Neurology, Hospital Neurology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Minga, Jamila, Assistant Professor of Head and Neck Surgery & Communication Sciences, Center for Cognitive Neuroscience
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Olsen, Maren Karine, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Shah, Shreyansh, Assistant Professor of Neurology, Neurology, Neurocritical Care
  • Sheng, Huaxin, Associate Professor in Anesthesiology, Anesthesiology